FILENAME	BARCODE_PLATEID	DATACOLLECTOR	IONSOURCE	IONMODE	INSTRUMENT	LIBQUALITY	PI	PROJECT_ID	DATE_TEMPLATE_CREATED	96_WELL_POSITION	COMPOUND_NAME	MOLECULAR_FORMULA	SMILES	INCHI	ACQUISITION	PUBMED	CASNUMBER	MS2 Count
GNPS00007_A2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	CYTIDINE MONOPHOSPHATE	C9H14N3O8P	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		63-37-6	4
GNPS00007_A3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	URIDINE MONOPHOSPHATE	C9H13N2O9P	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		58-97-9	3
GNPS00007_A4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	ADENOSINE 2',3'-CYCLIC PHOSPHATE	C10H12N5O6P	NC1=NC=NC2=C1N=CN2C1OC(CO)C2OP(O)(=O)OC12		Commercial		37063-35-7	3
GNPS00007_A5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	CYCLIC AMP	C10H12N5O6P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O		Commercial		37839-81-9	6
GNPS00007_A6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	CYCLIC AMP	C10H12N5O6P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O		Commercial		60-92-4	6
GNPS00007_A7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	DEOXYADENOSINE MONOPHOSPHATE	C10H14N5O6P	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1		Commercial		653-63-4	3
GNPS00007_A8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	NICOTINAMIDE MONONUCLEOTIDE	C11H15N2O8P	NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP(O)([O-])=O)[C@@H](O)[C@H]1O		Commercial		1094-61-7	1
GNPS00007_A9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	AICAR	C9H15N4O8P	NC(=O)C1=C(N)N(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		3031-94-5	2
GNPS00007_A10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	FRUCTOSE BISPHOSPHATE	C6H14O12P2	O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		488-69-7	0
GNPS00007_A11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	TREHALOSE	C12H22O11	OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		6138-23-4	2
GNPS00007_A12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	LACTOSE	C12H22O11	OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O		Commercial		64044-51-5	2
GNPS00007_B1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	LAUROYLCARNITINE	C19H37NO4	CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C		Commercial		25518-54-1	2
GNPS00007_B2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	THIAMINE MONOPHOSPHATE	C12H17N4O4PS	CC1=C(CCOP(O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N		Commercial		273724-21-3	1
GNPS00007_B3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	CYCLIC GMP	C10H12N5O7P	NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1		Commercial		40732-48-7	3
GNPS00007_B4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	DEOXYGUANOSINE-MONOPHOSPHATE	C10H14N5O7P	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)N1		Commercial			1
GNPS00007_B5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	ADENOSINE-MONOPHOSPHATE	C10H14N5O7P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		4578-31-8	3
GNPS00007_B6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	DEHYDROASCORBATE	C6H6O6	C([C@@H]([C@@H]1C(=O)C(=O)C(=O)O1)O)O		Commercial		72691-25-9	0
GNPS00007_B7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	INOSINE MONOPHOSPHATE	C10H13N4O8P	O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		131-99-7	5
GNPS00007_B8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	INOSINE-MONOPHOSPHATE	C10H13N4O8P	O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		352195-40-5	5
GNPS00007_B9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	THYROTROPIN RELEASING HORMONE	C16H22N6O4	C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N		Commercial		24305-27-9	3
GNPS00007_B10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	CORTISOL	C21H30O5	[H][C@@]12CC[C@@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C		Commercial		50-23-7	4
GNPS00007_B11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	GUANOSINE MONOPHOSPHATE	C10H14N5O8P	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		1333479	2
GNPS00007_B12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	XANTHOSINE-MONOPHOSPHATE	C10H13N4O9P	C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)NC(=O)NC2=O		Commercial		25899-70-1	2
GNPS00007_C1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	RIBOFLAVIN	C17H20N4O6	CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1		Commercial		83-88-5	3
GNPS00007_C2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	S-ADENOSYLHOMOCYSTEINE	C14H20N6O5S	N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O		Commercial		979-92-0	3
GNPS00007_C3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	DEOXYCYTIDINE-DIPHOSPHATE	C9H15N3O10P2	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1		Commercial		151151-32-5	1
GNPS00007_C4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	PHOSPHORIBOSYL PYROPHOSPHATE	C5H13O14P3	O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		108321-05-7	0
GNPS00007_C5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	S-HEXYL-GLUTATHIONE	C16H29N3O6S	CCCCCCSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N		Commercial		24425-56-7	2
GNPS00007_C6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	PREGNENOLONE SULFATE	C21H32O5S	CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)O)C)C		Commercial			1
GNPS00007_C7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	S-ADENOSYLMETHIONINE	C15H22N6O5S	C[S+](C[C@H]1O[C@@H](N2C=NC3=C(N=CN=C23)N)[C@@H]([C@@H]1O)O)CC[C@@H](C([O-])=O)N		Commercial		17176-17-9	1
GNPS00007_C8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	PALMITOYLCARNITINE	C23H45NO4	CCCCCCCCCCCCCCCC(OC(C[N+](C)(C)C)CC([O-])=O)=O		Commercial		6865-14-1	2
GNPS00007_C9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	CYTIDINE DIPHOSPHATE	C9H15N3O11P2	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34393-59-4	1
GNPS00007_C10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	URIDINE 5'-DIPHOSPHATE	C9H14N2O12P2	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		27821-45-0	1
GNPS00007_C11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	CORTISOL 21-ACETATE	C23H32O6	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O		Commercial		50-03-3	2
GNPS00007_C12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	THIAMINE PYROPHOSPHATE	C12H18N4O7P2S	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO[P@@](O)(OP([O-])(O)=O)=O		Commercial		154-87-0	2
GNPS00007_D1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	ADENOSINE 5'-DIPHOSPHATE	C10H15N5O10P2	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		20398-34-9	1
GNPS00007_D2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	DGDP	C10H15N5O10P2	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)N1		Commercial		102783-74-4	1
GNPS00007_D3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	ADENOSINE 3',5'-DIPHOSPHATE	C10H15N5O10P2	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O		Commercial		75431-54-8	2
GNPS00007_D4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	INOSINE 5'-DIPHOSPHATE	C10H14N4O11P2	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)OC([C@@H]1O)N1C=NC2=C1NC=NC2=O		Commercial		81012-88-6	1
GNPS00007_D5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	3,5-DIIODO-L-TYROSINE	C9H9I2NO3	N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(O)=O		Commercial		18835-59-1	2
GNPS00007_D6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	FOLATE	C19H19N7O6	NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1		Commercial		59-30-3	1
GNPS00007_D7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	GUANOSINE DIPHOSPHATE	C10H15N5O11P2	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		43139-22-6	1
GNPS00007_D8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	DIHYDROFOLATE	C19H21N7O6	NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1		Commercial		207226-40-2	0
GNPS00007_D9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	TETRAHYDROFOLATE	C19H23N7O6	NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2)N1		Commercial		135-16-0	0
GNPS00007_D10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	CDP-ETHANOLAMINE	C11H20N4O11P2	NCCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O		Commercial		3036-18-8 FREE BASE	2
GNPS00007_D11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	GLYCOCHENODEOXYCHOLATE	C26H43NO5	CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C		Commercial		16564-43-5	4
GNPS00007_D12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	GLYCOCHOLATE	C26H43NO6	[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)CC2C[C@H](O)CC[C@]12C		Commercial		475-31-0	5
GNPS00007_E1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	DEOXYURIDINE TRIPHOSPHATE	C9H15N2O14P3	O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		102814-08-4	1
GNPS00007_E2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	CYTIDINE TRIPHOSPHATE	C9H16N3O14P3	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		36051-68-0	1
GNPS00007_E3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	URIDINE TRIPHOSPHATE	C9H15N2O15P3	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		19817-92-6	1
GNPS00007_E4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	URIDINE TRIPHOSPHATE	C9H15N2O15P3	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		108321-53-5	1
GNPS00007_E5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	CITICOLINE	C14H26N4O11P2	C[N+](C)(C)CCOP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O		Commercial		33818-15-4	3
GNPS00007_E6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	DEOXYADENOSINE TRIPHOSPHATE	C10H16N5O12P3	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1		Commercial		74299-50-6	1
GNPS00007_E7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	RAFFINOSE	C18H32O16	OC[C@H]1O[C@@](CO)(OC2O[C@H](COC3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O		Commercial		17629-30-0	2
GNPS00007_E8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	DGTP	C10H16N5O13P3	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)N1		Commercial		93919-41-6	0
GNPS00007_E9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	ADENOSINE TRIPHOSPHATE	C10H16N5O13P3	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34369-07-8	2
GNPS00007_E10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	ADENOSINE TRIPHOSPHATE	C10H16N5O13P3	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34369-07-8	2
GNPS00007_E11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	INOSINE TRIPHOSPHATE	C10H15N4O14P3	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN=C2O		Commercial		35908-31-7	1
GNPS00007_E12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	GUANOSINE TRIPHOSPHATE	C10H16N5O14P3	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		36051-31-7	1
GNPS00007_F1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	3,5-DIIODO-L-THYRONINE	C15H13I2NO4	NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(O)=O		Commercial		1041-01-6	2
GNPS00007_F2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	ADENOSINE DIPHOSPHATE RIBOSE	C15H23N5O14P2	NC1=C2N=CN(C3OC(COP(O)(=O)OP(O)(=O)OCC4OC(O)C(O)C4O)C(O)C3O)C2=NC=N1		Commercial		68414-18-6	2
GNPS00007_F3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	DTDP-D-GLUCOSE	C16H26N2O16P2	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O		Commercial		148296-43-9	1
GNPS00007_F4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	DIDECANOYL-GLYCEROPHOSPHOCHOLINE	C28H56NO8P	CCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC		Commercial		3436-44-0	2
GNPS00007_F5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	URIDINE DIPHOSPHATE GLUCOSE	C15H24N2O17P2	OC[C@@H]1OC(OP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)N2C=CC(=O)NC2=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		28053-08-9	1
GNPS00007_F6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	URIDINE DIPHOSPHATEGALACTOSE	C15H24N2O17P2	OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O		Commercial		137868-52-1	1
GNPS00007_F7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	URIDINE DIPHOSPHATE GLUCOSE	C15H24N2O17P2	C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O		Commercial		133-89-1	1
GNPS00007_F8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	URIDINE DIPHOSPHATE GLUCURONIC ACID	C15H22N2O18P2	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O		Commercial		63700-19-6	1
GNPS00007_F9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	BILIVERDIN	C33H34N4O6	CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N\C(=C\C2=NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O		Commercial		55482-27-4	1
GNPS00007_F10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	BILIRUBIN	C33H36N4O6	CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\C=C2/NC(=O)C(C=C)=C2C)N1		Commercial		635-65-4	0
GNPS00007_F11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	ADP-GLUCOSE	C16H25N5O15P2	NC1=C2N=CN([C@@H]3O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1		Commercial		102129-65-7	1
GNPS00007_F12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GUANOSINE DIPHOSPHATE MANNOSE	C16H25N5O16P2	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		103301-73-1	1
GNPS00007_G1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	URIDINE DIPHOSPHATE-N-ACETYLGALACTOSAMINE	C17H27N3O17P2	CC(=O)NC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1OC(C(O)C1O)N1C=CC(=O)NC1=O		Commercial		108320-87-2	1
GNPS00007_G2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	URIDINE DIPHOSPHATE-N-ACETYLGLUCOSAMINE	C17H27N3O17P2	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		91183-98-1	1
GNPS00007_G3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	PHYTATE	C6H18O24P6	OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O		Commercial		129832-03-7	0
GNPS00007_G4_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	3-METHYLCROTONYL-COA	C26H42N7O17P3S	CC(C)=CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N		Commercial		108347-83-7	0
GNPS00007_G5_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE	C21H27N7O14P2	NC(C1=C[N+]([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP([O-])(OP(O)(OC[C@H]3O[C@@H](N4C=NC5=C4N=CN=C5N)[C@@H]([C@@H]3O)O)=O)=O)=CC=C1)=O		Commercial		53-84-9	0
GNPS00007_G6_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	NICOTINAMIDE HYPOXANTHINE DINUCLEOTIDE	C21H26N6O15P2	O=P([O-])(OP(O)(OCC1C(O)C(O)C(N2C=NC3=C2NC=NC3=O)O1)=O)OCC(O4)C(O)C(O)C4[N+]5=CC=CC(C(N)=O)=C5		Commercial		104809-38-3	1
GNPS00007_G7_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	STACHYOSE	C24H42O21	OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO[C@H]3O[C@H](CO[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O		Commercial		54261-98-2	2
GNPS00007_G8_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	NADP	C21H28N7O17P3	O=P([O-])(OP(O)(OCC1C(O)C(OP(O)(O)=O)C(N2C=NC3=C2N=CN=C3N)O1)=O)OCC(O4)C(O)C(O)C4[N+]5=CC=CC(C(N)=O)=C5		Commercial		698999-85-8	1
GNPS00007_G9_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE	C21H27N6O18P3	O=P([O-])(OP(O)(OC[C@@H]1[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](N2C=NC3=C2N=CN=C3N)O1)=O)OCC(O4)[C@H](O)[C@H](O)[C@H]4[N+]5=CC=CC(C(O)=O)=C5		Commercial		5502-96-5	1
GNPS00007_G10_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	NADPH	C21H30N7O17P3	NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O		Commercial		2646-71-1	0
GNPS00007_G11_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	COENZYME A	C21H36N7O16P3S	CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)C(O)C(=O)NCCC(=O)NCCS		Commercial		55672-92-9	1
GNPS00007_G12_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	FAD	C27H33N9O15P2	CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2		Commercial		84366-81-4	1
GNPS00007_H1_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	CYTOCHROME C	C42H52FeN8O6S2	CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C(C)SCC(C(=O)NC)N)C)C(C)SCC(C(=O)NC)N)C)C(=C3CCC(=O)O)C)CCC(=O)O.[Fe+2]		Commercial		9007-43-6	0
GNPS00007_H2_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	3-HYDROXY-3-METHYLGLUTARYL-COA	C27H44N7O20P3S	CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C2N=CN=C3N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(C)(CC(=O)O)O)O		Commercial		 103476-21-7 (anhydrous)	0
GNPS00007_H3_p.mzXML	GNPS00007	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	CYANOCOBALAMIN	C63H89CoN14O14P	[C@H]1([C@H]2[C@@H](CO)O[C@@H]1N1C3=CC(=C(C)C=C3[N]([Co]345(N6C7=C(C8=[N]3C(C([C@@H]8CCC(N)=O)(C)C)=CC3=[N]4C(=C(C4=[N]5[C@@]([C@]6([C@@H]([C@@]7(C)CCC(=O)NC[C@@]([H])(C)OP(O)(=O)O2)CC(N)=O)[H])([C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]3CCC(N)=O)(C)CC(N)=O)C)C#N)=C1)C)O		Commercial		68-19-9	0
GNPS00007_A1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A1	CYTIDINE MONOPHOSPHATE	C9H14N3O8P	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		63-37-6	4
GNPS00007_A2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	CYTIDINE MONOPHOSPHATE	C9H14N3O8P	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		63-37-6	4
GNPS00007_A3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	URIDINE MONOPHOSPHATE	C9H13N2O9P	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		58-97-9	3
GNPS00007_A4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	ADENOSINE 2',3'-CYCLIC PHOSPHATE	C10H12N5O6P	NC1=NC=NC2=C1N=CN2C1OC(CO)C2OP(O)(=O)OC12		Commercial		37063-35-7	3
GNPS00007_A5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	CYCLIC AMP	C10H12N5O6P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O		Commercial		37839-81-9	6
GNPS00007_A6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	CYCLIC AMP	C10H12N5O6P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1O		Commercial		60-92-4	6
GNPS00007_A7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	DEOXYADENOSINE MONOPHOSPHATE	C10H14N5O6P	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1		Commercial		653-63-4	3
GNPS00007_A8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	NICOTINAMIDE MONONUCLEOTIDE	C11H15N2O8P	NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP(O)([O-])=O)[C@@H](O)[C@H]1O		Commercial		1094-61-7	1
GNPS00007_A9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	AICAR	C9H15N4O8P	NC(=O)C1=C(N)N(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		3031-94-5	2
GNPS00007_A10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	FRUCTOSE BISPHOSPHATE	C6H14O12P2	O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		488-69-7	0
GNPS00007_A11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	TREHALOSE	C12H22O11	OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		6138-23-4	2
GNPS00007_A12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	LACTOSE	C12H22O11	OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O		Commercial		64044-51-5	2
GNPS00007_B1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	LAUROYLCARNITINE	C19H37NO4	CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C		Commercial		25518-54-1	2
GNPS00007_B2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	THIAMINE MONOPHOSPHATE	C12H17N4O4PS	CC1=C(CCOP(O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N		Commercial		273724-21-3	1
GNPS00007_B3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	CYCLIC GMP	C10H12N5O7P	NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1		Commercial		40732-48-7	3
GNPS00007_B4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	DEOXYGUANOSINE-MONOPHOSPHATE	C10H14N5O7P	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)N1		Commercial			1
GNPS00007_B5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	ADENOSINE-MONOPHOSPHATE	C10H14N5O7P	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		4578-31-8	3
GNPS00007_B6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	DEHYDROASCORBATE	C6H6O6	C([C@@H]([C@@H]1C(=O)C(=O)C(=O)O1)O)O		Commercial		72691-25-9	0
GNPS00007_B7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	INOSINE MONOPHOSPHATE	C10H13N4O8P	O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		131-99-7	5
GNPS00007_B8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	INOSINE-MONOPHOSPHATE	C10H13N4O8P	O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		352195-40-5	5
GNPS00007_B9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	THYROTROPIN RELEASING HORMONE	C16H22N6O4	C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N		Commercial		24305-27-9	3
GNPS00007_B10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	CORTISOL	C21H30O5	[H][C@@]12CC[C@@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C		Commercial		50-23-7	4
GNPS00007_B11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	GUANOSINE MONOPHOSPHATE	C10H14N5O8P	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		1333479	2
GNPS00007_B12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	XANTHOSINE-MONOPHOSPHATE	C10H13N4O9P	C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)NC(=O)NC2=O		Commercial		25899-70-1	2
GNPS00007_C1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	RIBOFLAVIN	C17H20N4O6	CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1		Commercial		83-88-5	3
GNPS00007_C2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	S-ADENOSYLHOMOCYSTEINE	C14H20N6O5S	N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O		Commercial		979-92-0	3
GNPS00007_C3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	DEOXYCYTIDINE-DIPHOSPHATE	C9H15N3O10P2	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1		Commercial		151151-32-5	1
GNPS00007_C4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	PHOSPHORIBOSYL PYROPHOSPHATE	C5H13O14P3	O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		108321-05-7	0
GNPS00007_C5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	S-HEXYL-GLUTATHIONE	C16H29N3O6S	CCCCCCSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N		Commercial		24425-56-7	2
GNPS00007_C6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	PREGNENOLONE SULFATE	C21H32O5S	CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)O)C)C		Commercial			1
GNPS00007_C7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	S-ADENOSYLMETHIONINE	C15H22N6O5S	C[S+](C[C@H]1O[C@@H](N2C=NC3=C(N=CN=C23)N)[C@@H]([C@@H]1O)O)CC[C@@H](C([O-])=O)N		Commercial		17176-17-9	1
GNPS00007_C8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	PALMITOYLCARNITINE	C23H45NO4	CCCCCCCCCCCCCCCC(OC(C[N+](C)(C)C)CC([O-])=O)=O		Commercial		6865-14-1	2
GNPS00007_C9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	CYTIDINE DIPHOSPHATE	C9H15N3O11P2	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34393-59-4	1
GNPS00007_C10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	URIDINE 5'-DIPHOSPHATE	C9H14N2O12P2	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		27821-45-0	1
GNPS00007_C11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	CORTISOL 21-ACETATE	C23H32O6	CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O		Commercial		50-03-3	2
GNPS00007_C12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	THIAMINE PYROPHOSPHATE	C12H18N4O7P2S	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO[P@@](O)(OP([O-])(O)=O)=O		Commercial		154-87-0	2
GNPS00007_D1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	ADENOSINE 5'-DIPHOSPHATE	C10H15N5O10P2	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		20398-34-9	1
GNPS00007_D2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	DGDP	C10H15N5O10P2	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)N1		Commercial		102783-74-4	1
GNPS00007_D3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	ADENOSINE 3',5'-DIPHOSPHATE	C10H15N5O10P2	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O		Commercial		75431-54-8	2
GNPS00007_D4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	INOSINE 5'-DIPHOSPHATE	C10H14N4O11P2	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)OC([C@@H]1O)N1C=NC2=C1NC=NC2=O		Commercial		81012-88-6	1
GNPS00007_D5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	3,5-DIIODO-L-TYROSINE	C9H9I2NO3	N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(O)=O		Commercial		18835-59-1	2
GNPS00007_D6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	FOLATE	C19H19N7O6	NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1		Commercial		59-30-3	1
GNPS00007_D7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	GUANOSINE DIPHOSPHATE	C10H15N5O11P2	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		43139-22-6	1
GNPS00007_D8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	DIHYDROFOLATE	C19H21N7O6	NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1		Commercial		207226-40-2	0
GNPS00007_D9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	TETRAHYDROFOLATE	C19H23N7O6	NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2)N1		Commercial		135-16-0	0
GNPS00007_D10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	CDP-ETHANOLAMINE	C11H20N4O11P2	NCCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O		Commercial		3036-18-8 FREE BASE	2
GNPS00007_D11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	GLYCOCHENODEOXYCHOLATE	C26H43NO5	CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C		Commercial		16564-43-5	4
GNPS00007_D12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	GLYCOCHOLATE	C26H43NO6	[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)CC2C[C@H](O)CC[C@]12C		Commercial		475-31-0	5
GNPS00007_E1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	DEOXYURIDINE TRIPHOSPHATE	C9H15N2O14P3	O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		102814-08-4	1
GNPS00007_E2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	CYTIDINE TRIPHOSPHATE	C9H16N3O14P3	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		36051-68-0	1
GNPS00007_E3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	URIDINE TRIPHOSPHATE	C9H15N2O15P3	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		19817-92-6	1
GNPS00007_E4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	URIDINE TRIPHOSPHATE	C9H15N2O15P3	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O		Commercial		108321-53-5	1
GNPS00007_E5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	CITICOLINE	C14H26N4O11P2	C[N+](C)(C)CCOP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O		Commercial		33818-15-4	3
GNPS00007_E6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	DEOXYADENOSINE TRIPHOSPHATE	C10H16N5O12P3	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1		Commercial		74299-50-6	1
GNPS00007_E7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	RAFFINOSE	C18H32O16	OC[C@H]1O[C@@](CO)(OC2O[C@H](COC3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O		Commercial		17629-30-0	2
GNPS00007_E8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	DGTP	C10H16N5O13P3	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)N1		Commercial		93919-41-6	0
GNPS00007_E9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	ADENOSINE TRIPHOSPHATE	C10H16N5O13P3	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34369-07-8	2
GNPS00007_E10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	ADENOSINE TRIPHOSPHATE	C10H16N5O13P3	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		34369-07-8	2
GNPS00007_E11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	INOSINE TRIPHOSPHATE	C10H15N4O14P3	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN=C2O		Commercial		35908-31-7	1
GNPS00007_E12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	GUANOSINE TRIPHOSPHATE	C10H16N5O14P3	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		36051-31-7	1
GNPS00007_F1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	3,5-DIIODO-L-THYRONINE	C15H13I2NO4	NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(O)=O		Commercial		1041-01-6	2
GNPS00007_F2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	ADENOSINE DIPHOSPHATE RIBOSE	C15H23N5O14P2	NC1=C2N=CN(C3OC(COP(O)(=O)OP(O)(=O)OCC4OC(O)C(O)C4O)C(O)C3O)C2=NC=N1		Commercial		68414-18-6	2
GNPS00007_F3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	DTDP-D-GLUCOSE	C16H26N2O16P2	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O		Commercial		148296-43-9	1
GNPS00007_F4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	DIDECANOYL-GLYCEROPHOSPHOCHOLINE	C28H56NO8P	CCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC		Commercial		3436-44-0	2
GNPS00007_F5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	URIDINE DIPHOSPHATE GLUCOSE	C15H24N2O17P2	OC[C@@H]1OC(OP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)N2C=CC(=O)NC2=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		28053-08-9	1
GNPS00007_F6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	URIDINE DIPHOSPHATEGALACTOSE	C15H24N2O17P2	OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O		Commercial		137868-52-1	1
GNPS00007_F7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	URIDINE DIPHOSPHATE GLUCOSE	C15H24N2O17P2	C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O		Commercial		133-89-1	1
GNPS00007_F8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	URIDINE DIPHOSPHATE GLUCURONIC ACID	C15H22N2O18P2	O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O		Commercial		63700-19-6	1
GNPS00007_F9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	BILIVERDIN	C33H34N4O6	CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N\C(=C\C2=NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O		Commercial		55482-27-4	1
GNPS00007_F10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	BILIRUBIN	C33H36N4O6	CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\C=C2/NC(=O)C(C=C)=C2C)N1		Commercial		635-65-4	0
GNPS00007_F11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	ADP-GLUCOSE	C16H25N5O15P2	NC1=C2N=CN([C@@H]3O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1		Commercial		102129-65-7	1
GNPS00007_F12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GUANOSINE DIPHOSPHATE MANNOSE	C16H25N5O16P2	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		103301-73-1	1
GNPS00007_G1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	URIDINE DIPHOSPHATE-N-ACETYLGALACTOSAMINE	C17H27N3O17P2	CC(=O)NC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1OC(C(O)C1O)N1C=CC(=O)NC1=O		Commercial		108320-87-2	1
GNPS00007_G2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	URIDINE DIPHOSPHATE-N-ACETYLGLUCOSAMINE	C17H27N3O17P2	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		91183-98-1	1
GNPS00007_G3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	PHYTATE	C6H18O24P6	OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O		Commercial		129832-03-7	0
GNPS00007_G4_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	3-METHYLCROTONYL-COA	C26H42N7O17P3S	CC(C)=CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N		Commercial		108347-83-7	0
GNPS00007_G5_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE	C21H27N7O14P2	NC(C1=C[N+]([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP([O-])(OP(O)(OC[C@H]3O[C@@H](N4C=NC5=C4N=CN=C5N)[C@@H]([C@@H]3O)O)=O)=O)=CC=C1)=O		Commercial		53-84-9	0
GNPS00007_G6_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	NICOTINAMIDE HYPOXANTHINE DINUCLEOTIDE	C21H26N6O15P2	O=P([O-])(OP(O)(OCC1C(O)C(O)C(N2C=NC3=C2NC=NC3=O)O1)=O)OCC(O4)C(O)C(O)C4[N+]5=CC=CC(C(N)=O)=C5		Commercial		104809-38-3	1
GNPS00007_G7_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	STACHYOSE	C24H42O21	OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO[C@H]3O[C@H](CO[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O		Commercial		54261-98-2	2
GNPS00007_G8_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	NADP	C21H28N7O17P3	O=P([O-])(OP(O)(OCC1C(O)C(OP(O)(O)=O)C(N2C=NC3=C2N=CN=C3N)O1)=O)OCC(O4)C(O)C(O)C4[N+]5=CC=CC(C(N)=O)=C5		Commercial		698999-85-8	1
GNPS00007_G9_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE	C21H27N6O18P3	O=P([O-])(OP(O)(OC[C@@H]1[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](N2C=NC3=C2N=CN=C3N)O1)=O)OCC(O4)[C@H](O)[C@H](O)[C@H]4[N+]5=CC=CC(C(O)=O)=C5		Commercial		5502-96-5	1
GNPS00007_G10_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	NADPH	C21H30N7O17P3	NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O		Commercial		2646-71-1	0
GNPS00007_G11_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	COENZYME A	C21H36N7O16P3S	CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)C(O)C(=O)NCCC(=O)NCCS		Commercial		55672-92-9	1
GNPS00007_G12_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	FAD	C27H33N9O15P2	CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2		Commercial		84366-81-4	1
GNPS00007_H1_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	CYTOCHROME C	C42H52FeN8O6S2	CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C(C)SCC(C(=O)NC)N)C)C(C)SCC(C(=O)NC)N)C)C(=C3CCC(=O)O)C)CCC(=O)O.[Fe+2]		Commercial		9007-43-6	0
GNPS00007_H2_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	3-HYDROXY-3-METHYLGLUTARYL-COA	C27H44N7O20P3S	CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C2N=CN=C3N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(C)(CC(=O)O)O)O		Commercial		 103476-21-7 (anhydrous)	0
GNPS00007_H3_n.mzXML	GNPS00007	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	CYANOCOBALAMIN	C63H89CoN14O14P	[C@H]1([C@H]2[C@@H](CO)O[C@@H]1N1C3=CC(=C(C)C=C3[N]([Co]345(N6C7=C(C8=[N]3C(C([C@@H]8CCC(N)=O)(C)C)=CC3=[N]4C(=C(C4=[N]5[C@@]([C@]6([C@@H]([C@@]7(C)CCC(=O)NC[C@@]([H])(C)OP(O)(=O)O2)CC(N)=O)[H])([C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]3CCC(N)=O)(C)CC(N)=O)C)C#N)=C1)C)O		Commercial		68-19-9	0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
GNPS00006_A2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	DIAMINOPIMELATE	C7H14N2O4	N[C@@H](CCC[C@H](N)C(O)=O)C(O)=O		Commercial		583-93-7	0
GNPS00006_A3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	N-ACETYLMETHIONINE	C7H13NO3S	CSCCC(NC(C)=O)C(O)=O		Commercial		1115-47-5	3
GNPS00006_A4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	CITRATE	C6H8O7	OC(=O)CC(O)(CC(O)=O)C(O)=O		Commercial		77-92-9	1
GNPS00006_A5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	ISOCITRATE	C6H8O7	OC(C(CC(O)=O)C(O)=O)C(O)=O		Commercial		1637-73-6	0
GNPS00006_A6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	QUINATE	C7H12O6	OC1C[C@@](O)(C[C@@H](O)[C@H]1O)C(O)=O		Commercial		77-95-2	3
GNPS00006_A7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	GLUCURONATE	C6H10O7	O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O		Commercial		207300-70-7	2
GNPS00006_A8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	GALACTURONATE	C6H10O7	C1(C(C(OC(C1O)O)C(=O)O)O)O		Commercial		91510-62-2	2
GNPS00006_A9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	FERULATE	C10H10O4	COC1=C(O)C=CC(\C=C\C(O)=O)=C1		Commercial		1135-24-6	3
GNPS00006_A10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	METHYL GALACTOSIDE	C7H14O6	COC1OC(CO)C(O)C(O)C1O		Commercial		1824-94-8	1
GNPS00006_A11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	CAFFEINE	C8H10N4O2	CN1C=NC2=C1C(=O)N(C)C(=O)N2C		Commercial		58-08-2	2
GNPS00006_A12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	GLUCOSAMINATE	C6H13NO6	C(C(C(C(C(C(=O)O)N)O)O)O)O		Commercial		3646-68-2	3
GNPS00006_B1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	GLUCONATE	C6H12O7	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		526-95-4	4
GNPS00006_B2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	GLUCONATE	C6H12O7	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		527-07-1	4
GNPS00006_B3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	SELENOMETHIONINE	C5H11NO2Se	C[Se]CCC(N)C(O)=O		Commercial		1464-42-2	2
GNPS00006_B4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	L-DOPA	C9H11NO4	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O		Commercial		59-92-7	1
GNPS00006_B5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	N,N-DIMETHYL-ARGININE	C8H18N4O2	CN(C)C(=NCCCC(C(=O)O)N)N		Commercial		1266235-58-8	6
GNPS00006_B6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	N,N-DIMETHYLARGININE	C8H18N4O2	CN(C)C(=NCCCC(C(=O)O)N)N		Commercial		220805-22-1	6
GNPS00006_B7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	SPERMINE	C10H26N4	NCCCNCCCCNCCCN		Commercial		306-67-2	1
GNPS00006_B8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	INDOLE-3-PYRUVATE	C11H9NO3	OC(=O)C(=O)CC1=CNC2=CC=CC=C12		Commercial		392-12-1	0
GNPS00006_B9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	L-TRYPTOPHANAMIDE	C11H13N3O	NC(CC1=CNC2=CC=CC=C12)C(N)=O		Commercial		5022-65-1	3
GNPS00006_B10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	O-ACETYLCARNITINE	C9H17NO4	CC(=O)OC(CC([O-])=O)C[N+](C)(C)C		Commercial		5080-50-2	2
GNPS00006_B11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	N6-(DELTA2-ISOPENTENYL)-ADENINE	C10H13N5	CC(=CCNC1=NC=NC2=C1NC=N2)C		Commercial		2365-40-4	0
GNPS00006_B12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	TRYPTOPHAN	C11H12N2O2	N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O		Commercial		73-22-3	3
GNPS00006_C1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	TRYPTOPHAN	C11H12N2O2	N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O		Commercial		153-94-6	3
GNPS00006_C2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	XANTHURENATE	C10H7NO4	OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1		Commercial		59-00-7	2
GNPS00006_C3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	LIPOAMIDE	C8H15NOS2	NC(=O)CCCCC1CCSS1		Commercial		940-69-2	1
GNPS00006_C4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	OXALOMALATE	C6H6O8	C(C(C(=O)O)O)(C(=O)C(=O)O)C(=O)O		Commercial		89304-26-7	0
GNPS00006_C5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	N-ACETYLPHENYLALANINE	C11H13NO3	CC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O		Commercial		2018-61-3	4
GNPS00006_C6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	KYNURENINE	C10H12N2O3	N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O		Commercial		343-65-7	4
GNPS00006_C7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	KYNURENINE	C10H12N2O3	N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O		Commercial		2922-83-0	4
GNPS00006_C8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	GALACTARATE	C6H10O8	O[C@@H]([C@@H](O)[C@H](O)C(O)=O)[C@@H](O)C(O)=O		Commercial		526-99-8	2
GNPS00006_C9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	SACCHARATE	C6H10O8	OC(C(O)C(O)C(O)=O)C(O)C(O)=O		Commercial		576-42-1	2
GNPS00006_C10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	PHOSPHOCREATINE	C4H10N3O5P	CN(CC(O)=O)C(=N)NP(O)(O)=O		Commercial		19333-65-4	3
GNPS00006_C11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	PHOSPHOCREATINE	C4H10N3O5P	CN(CC(O)=O)C(=N)NP(O)(O)=O		Commercial		71519-72-7	3
GNPS00006_C12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	3-METHOXYTYROSINE	C10H13NO4	COC1=CC(CC(N)C(O)=O)=CC=C1O		Commercial		300-48-1	2
GNPS00006_D1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	INDOXYL SULFATE	C8H7NO4S	OS(=O)(=O)OC1=CNC2=CC=CC=C12		Commercial		2642-37-7	1
GNPS00006_D2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	O-SUCCINYL-HOMOSERINE	C8H13NO6	C(COC(=O)CCC(=O)O)C(C(=O)O)N		Commercial		1492-23-5	2
GNPS00006_D3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	PANTOTHENATE	C9H17NO5	CC(C)(CO)C(O)C(=O)NCCC(O)=O		Commercial		137-08-6	3
GNPS00006_D4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	5-HYDROXYTRYPTOPHAN	C11H12N2O3	NC(CC1=CNC2=C1C=C(O)C=C2)C(O)=O		Commercial		4350-09-8	3
GNPS00006_D5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOSYLAMINE	C8H16N2O5	CC(=O)NC1C(C(C(OC1N)CO)O)O		Commercial		4229-38-3	1
GNPS00006_D6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	N-ACETYLGLUCOSAMINE	C8H15NO6	CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		Commercial		7512-17-6	3
GNPS00006_D7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	N-ACETYLMANNOSAMINE	C8H15NO6	[H][C@@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O		Commercial		7772-94-3	2
GNPS00006_D8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	N-ACETYLGALACTOSAMINE	C8H15NO6	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O		Commercial		1811-31-0	2
GNPS00006_D9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	CYSTATHIONINE	C7H14N2O4S	N[C@@H](CCSC[C@H](N)C(O)=O)C(O)=O		Commercial		56-88-2	2
GNPS00006_D10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	HYDROXYKYNURENINE	C10H12N2O4	NC(CC(=O)C1=C(N)C(O)=CC=C1)C(O)=O		Commercial		2147-61-7	0
GNPS00006_D11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	3-NITRO-L-TYROSINE	C9H10N2O5	C1=CC(=C(C=C1CC(C(=O)O)N)[N+](=O)[O-])O		Commercial		621-44-3	2
GNPS00006_D12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	CARNOSINE	C9H14N4O3	NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O		Commercial		305-84-0	3
GNPS00006_E1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	DEOXYCYTIDINE	C9H13N3O4	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1		Commercial		951-77-9	5
GNPS00006_E2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	DEOXYURIDINE	C9H12N2O5	OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		951-78-0	2
GNPS00006_E3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	D-RIBOSE 5-PHOSPHATE	C5H11O8P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		18265-46-8	1
GNPS00006_E4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	MELATONIN	C13H16N2O2	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1		Commercial		73-31-4	4
GNPS00006_E5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	DIHYDROBIOPTERIN	C9H13N5O3	CC(C(C1=NC2=C(NC1)NC(=NC2=O)N)O)O		Commercial		6779-87-9	0
GNPS00006_E6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	CYSTINE	C6H12N2O4S2	N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O		Commercial		56-89-3	3
GNPS00006_E7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	ANSERINE	C10H16N4O3	CN1C=NC=C1C[C@H](NC(=O)CCN)C(O)=O		Commercial		10030-52-1	2
GNPS00006_E8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	LUMICHROME	C12H10N4O2	CC1=CC2=C(C=C1C)N=C3C(=N2)C(=O)NC(=O)N3		Commercial		1086-80-2	2
GNPS00006_E9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	THYMIDINE	C10H14N2O5	CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O		Commercial		50-89-5	2
GNPS00006_E10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	CYTIDINE	C9H13N3O5	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		Commercial		65-46-3	2
GNPS00006_E11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	URIDINE	C9H12N2O6	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		58-96-8	2
GNPS00006_E12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	N1-ACETYLSPERMINE	C12H28N4O	CC(=O)NCCCNCCCCNCCCN		Commercial		77928-70-2	2
GNPS00006_F1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	ISOPENTENYL PYROPHOSPHATE	C5H12O7P2	CC(=C)CCOP(O)(=O)OP(O)(O)=O		Commercial		116057-53-5	0
GNPS00006_F2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	GAMMA,GAMMA-DIMETHYLALLYL PYROPHOSPHATE	C5H12O7P2	C/C(C)=C\COP(O)(OP(O)(O)=O)=O		Commercial		1186-30-7	0
GNPS00006_F3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	N-ACETYLTRYPTOPHAN	C13H14N2O3	CC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O		Commercial		87-32-1	3
GNPS00006_F4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	PYRIDOXAL-PHOSPHATE	C8H10NO6P	CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O		Commercial		853645-22-4	0
GNPS00006_F5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	SELENOCYSTAMINE	C4H12N2Se2	C(C[Se][Se]CCN)N		Commercial		3542-13-0	1
GNPS00006_F6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	5'-DEOXYADENOSINE	C10H13N5O3	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12		Commercial		4754-39-6	2
GNPS00006_F7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	DEOXYADENOSINE	C10H13N5O3	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](CO)O1		Commercial		16373-93-6	2
GNPS00006_F8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	GLUCOSAMINE 6-SULFATE	C6H13NO8S	N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@@H](O)[C@@H]1O		Commercial		91674-26-9	3
GNPS00006_F9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	GLUCOSAMINE 6-PHOSPHATE	C6H14NO8P	N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O		Commercial		70442-23-8	4
GNPS00006_F10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	GLUCOSE 6-PHOSPHATE	C6H13O9P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		56-73-5	3
GNPS00006_F11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	GLUCOSE 6-PHOSPHATE	C6H13O9P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		103192-55-8	3
GNPS00006_F12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GALACTOSE 1-PHOSPHATE	C6H13O9P	OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O		Commercial		19046-60-7	1
GNPS00006_G1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	MANNOSE 6-PHOSPHATE	C6H13O9P	O[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O		Commercial		104872-94-8	1
GNPS00006_G2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	FRUCTOSE 6-PHOSPHATE	C6H13O9P	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O		Commercial		26177-86-6	1
GNPS00006_G3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	GLUCOSE 1-PHOSPHATE	C6H13O9P	OC[C@H]1OC(OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		56401-20-8	1
GNPS00006_G4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	THIAMINE	C12H17N4OS	CC1=C(CCO)SC=[N+]1CC1=C(N)N=C(C)N=C1		Commercial		67-03-8	0
GNPS00006_G5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	DEOXYGUANOSINE	C10H13N5O4	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1		Commercial		961-07-9	3
GNPS00006_G6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	ADENOSINE	C10H13N5O4	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		Commercial		58-61-7	3
GNPS00006_G7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	HOMOCYSTINE	C8H16N2O4S2	NC(CCSSCCC(N)C(O)=O)C(O)=O		Commercial		462-10-2	2
GNPS00006_G8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	INOSINE	C10H12N4O5	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		58-63-9	3
GNPS00006_G9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	GLUTARYLCARNITINE	C12H21NO6	C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CCCC(O)=O		Commercial		102636-82-8	0
GNPS00006_G10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	6-PHOSPHOGLUCONATE	C6H13O10P	O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		53411-70-4	2
GNPS00006_G11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	1-METHYLADENOSINE	C11H15N5O4	CN1C=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1=N		Commercial		15763-06-1	3
GNPS00006_G12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	GUANOSINE	C10H13N5O5	NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		118-00-3	3
GNPS00006_H1_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	XANTHOSINE	C10H12N4O6	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(O)N=C2O		Commercial		5968-90-1	2
GNPS00006_H2_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	OPHTHALMATE	C11H19N3O6	CC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O		Commercial		495-27-2	3
GNPS00006_H3_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	METHYLTHIOADENOSINE	C11H15N5O3S	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N		Commercial		2457-80-9	3
GNPS00006_H4_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H4	CYTIDINE 2',3'-CYCLIC PHOSPHATE	C9H12N3O7P	NC1=NC(=O)N(C=C1)C1O[C@H](CO)[C@H]2OP(O)(=O)O[C@@H]12		Commercial		15718-51-1	3
GNPS00006_H5_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H5	DEOXYCYTIDINE MONOPHOSPHATE	C9H14N3O7P	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1		Commercial		1032-65-1	3
GNPS00006_H6_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H6	GLUTATHIONE REDUCED	C10H17N3O6S	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O		Commercial		70-18-8	3
GNPS00006_H7_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H7	DEOXYURIDINE-MONOPHOSPHATE	C9H13N2O8P	C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)O)O		Commercial		42155-08-8	2
GNPS00006_H8_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H8	N-ACETYLNEURAMINATE	C11H19NO9	CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O		Commercial		131-48-6	5
GNPS00006_H9_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H9	RIBOSE 1,5-BISPHOSPHATE	C5H12O11P2	O[C@H]1[C@@H](O)[C@@H](OP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		14689-84-0	0
GNPS00006_H10_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H10	MELANIN	C18H10N2O4	CC1=C2NC=C3C2=C(C2=CNC4=C(C)C(=O)C(=O)C3=C24)C(=O)C1=O		Commercial		8049-97-6	0
GNPS00006_H11_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H11	THYMIDINE-MONOPHOSPHATE	C10H15N2O8P	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O		Commercial		33430-62-5	4
GNPS00006_H12_p.mzXML	GNPS00006	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H12	THYMIDINE-MONOPHOSPHATE	C10H15N2O8P	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O		Commercial		365-07-1	4
GNPS00006_A1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A1	N-ACETYLGLUTAMATE	C7H11NO5	CC(=O)NC(CCC(O)=O)C(O)=O		Commercial		1188-37-0	1
GNPS00006_A2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	DIAMINOPIMELATE	C7H14N2O4	N[C@@H](CCC[C@H](N)C(O)=O)C(O)=O		Commercial		583-93-7	0
GNPS00006_A3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	N-ACETYLMETHIONINE	C7H13NO3S	CSCCC(NC(C)=O)C(O)=O		Commercial		1115-47-5	3
GNPS00006_A4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	CITRATE	C6H8O7	OC(=O)CC(O)(CC(O)=O)C(O)=O		Commercial		77-92-9	1
GNPS00006_A5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	ISOCITRATE	C6H8O7	OC(C(CC(O)=O)C(O)=O)C(O)=O		Commercial		1637-73-6	0
GNPS00006_A6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	QUINATE	C7H12O6	OC1C[C@@](O)(C[C@@H](O)[C@H]1O)C(O)=O		Commercial		77-95-2	3
GNPS00006_A7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	GLUCURONATE	C6H10O7	O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O		Commercial		207300-70-7	2
GNPS00006_A8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	GALACTURONATE	C6H10O7	C1(C(C(OC(C1O)O)C(=O)O)O)O		Commercial		91510-62-2	2
GNPS00006_A9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	FERULATE	C10H10O4	COC1=C(O)C=CC(\C=C\C(O)=O)=C1		Commercial		1135-24-6	3
GNPS00006_A10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	METHYL GALACTOSIDE	C7H14O6	COC1OC(CO)C(O)C(O)C1O		Commercial		1824-94-8	1
GNPS00006_A11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	CAFFEINE	C8H10N4O2	CN1C=NC2=C1C(=O)N(C)C(=O)N2C		Commercial		58-08-2	2
GNPS00006_A12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	GLUCOSAMINATE	C6H13NO6	C(C(C(C(C(C(=O)O)N)O)O)O)O		Commercial		3646-68-2	3
GNPS00006_B1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	GLUCONATE	C6H12O7	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		526-95-4	4
GNPS00006_B2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	GLUCONATE	C6H12O7	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		527-07-1	4
GNPS00006_B3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	SELENOMETHIONINE	C5H11NO2Se	C[Se]CCC(N)C(O)=O		Commercial		1464-42-2	2
GNPS00006_B4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	L-DOPA	C9H11NO4	N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O		Commercial		59-92-7	1
GNPS00006_B5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	N,N-DIMETHYL-ARGININE	C8H18N4O2	CN(C)C(=NCCCC(C(=O)O)N)N		Commercial		1266235-58-8	6
GNPS00006_B6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	N,N-DIMETHYLARGININE	C8H18N4O2	CN(C)C(=NCCCC(C(=O)O)N)N		Commercial		220805-22-1	6
GNPS00006_B7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	SPERMINE	C10H26N4	NCCCNCCCCNCCCN		Commercial		306-67-2	1
GNPS00006_B8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	INDOLE-3-PYRUVATE	C11H9NO3	OC(=O)C(=O)CC1=CNC2=CC=CC=C12		Commercial		392-12-1	0
GNPS00006_B9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	L-TRYPTOPHANAMIDE	C11H13N3O	NC(CC1=CNC2=CC=CC=C12)C(N)=O		Commercial		5022-65-1	3
GNPS00006_B10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	O-ACETYLCARNITINE	C9H17NO4	CC(=O)OC(CC([O-])=O)C[N+](C)(C)C		Commercial		5080-50-2	2
GNPS00006_B11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	N6-(DELTA2-ISOPENTENYL)-ADENINE	C10H13N5	CC(=CCNC1=NC=NC2=C1NC=N2)C		Commercial		2365-40-4	0
GNPS00006_B12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	TRYPTOPHAN	C11H12N2O2	N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O		Commercial		73-22-3	3
GNPS00006_C1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	TRYPTOPHAN	C11H12N2O2	N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O		Commercial		153-94-6	3
GNPS00006_C2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	XANTHURENATE	C10H7NO4	OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1		Commercial		59-00-7	2
GNPS00006_C3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	LIPOAMIDE	C8H15NOS2	NC(=O)CCCCC1CCSS1		Commercial		940-69-2	1
GNPS00006_C4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	OXALOMALATE	C6H6O8	C(C(C(=O)O)O)(C(=O)C(=O)O)C(=O)O		Commercial		89304-26-7	0
GNPS00006_C5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	N-ACETYLPHENYLALANINE	C11H13NO3	CC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O		Commercial		2018-61-3	4
GNPS00006_C6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	KYNURENINE	C10H12N2O3	N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O		Commercial		343-65-7	4
GNPS00006_C7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	KYNURENINE	C10H12N2O3	N[C@@H](CC(=O)C1=CC=CC=C1N)C(O)=O		Commercial		2922-83-0	4
GNPS00006_C8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	GALACTARATE	C6H10O8	O[C@@H]([C@@H](O)[C@H](O)C(O)=O)[C@@H](O)C(O)=O		Commercial		526-99-8	2
GNPS00006_C9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	SACCHARATE	C6H10O8	OC(C(O)C(O)C(O)=O)C(O)C(O)=O		Commercial		576-42-1	2
GNPS00006_C10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	PHOSPHOCREATINE	C4H10N3O5P	CN(CC(O)=O)C(=N)NP(O)(O)=O		Commercial		19333-65-4	3
GNPS00006_C11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	PHOSPHOCREATINE	C4H10N3O5P	CN(CC(O)=O)C(=N)NP(O)(O)=O		Commercial		71519-72-7	3
GNPS00006_C12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	3-METHOXYTYROSINE	C10H13NO4	COC1=CC(CC(N)C(O)=O)=CC=C1O		Commercial		300-48-1	2
GNPS00006_D1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	INDOXYL SULFATE	C8H7NO4S	OS(=O)(=O)OC1=CNC2=CC=CC=C12		Commercial		2642-37-7	1
GNPS00006_D2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	O-SUCCINYL-HOMOSERINE	C8H13NO6	C(COC(=O)CCC(=O)O)C(C(=O)O)N		Commercial		1492-23-5	2
GNPS00006_D3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	PANTOTHENATE	C9H17NO5	CC(C)(CO)C(O)C(=O)NCCC(O)=O		Commercial		137-08-6	3
GNPS00006_D4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	5-HYDROXYTRYPTOPHAN	C11H12N2O3	NC(CC1=CNC2=C1C=C(O)C=C2)C(O)=O		Commercial		4350-09-8	3
GNPS00006_D5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOSYLAMINE	C8H16N2O5	CC(=O)NC1C(C(C(OC1N)CO)O)O		Commercial		4229-38-3	1
GNPS00006_D6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	N-ACETYLGLUCOSAMINE	C8H15NO6	CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		Commercial		7512-17-6	3
GNPS00006_D7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	N-ACETYLMANNOSAMINE	C8H15NO6	[H][C@@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O		Commercial		7772-94-3	2
GNPS00006_D8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	N-ACETYLGALACTOSAMINE	C8H15NO6	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O		Commercial		1811-31-0	2
GNPS00006_D9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	CYSTATHIONINE	C7H14N2O4S	N[C@@H](CCSC[C@H](N)C(O)=O)C(O)=O		Commercial		56-88-2	2
GNPS00006_D10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	HYDROXYKYNURENINE	C10H12N2O4	NC(CC(=O)C1=C(N)C(O)=CC=C1)C(O)=O		Commercial		2147-61-7	0
GNPS00006_D11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	3-NITRO-L-TYROSINE	C9H10N2O5	C1=CC(=C(C=C1CC(C(=O)O)N)[N+](=O)[O-])O		Commercial		621-44-3	2
GNPS00006_D12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	CARNOSINE	C9H14N4O3	NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O		Commercial		305-84-0	3
GNPS00006_E1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	DEOXYCYTIDINE	C9H13N3O4	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1		Commercial		951-77-9	5
GNPS00006_E2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	DEOXYURIDINE	C9H12N2O5	OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		951-78-0	2
GNPS00006_E3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	D-RIBOSE 5-PHOSPHATE	C5H11O8P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O		Commercial		18265-46-8	1
GNPS00006_E4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	MELATONIN	C13H16N2O2	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1		Commercial		73-31-4	4
GNPS00006_E5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	DIHYDROBIOPTERIN	C9H13N5O3	CC(C(C1=NC2=C(NC1)NC(=NC2=O)N)O)O		Commercial		6779-87-9	0
GNPS00006_E6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	CYSTINE	C6H12N2O4S2	N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O		Commercial		56-89-3	3
GNPS00006_E7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	ANSERINE	C10H16N4O3	CN1C=NC=C1C[C@H](NC(=O)CCN)C(O)=O		Commercial		10030-52-1	2
GNPS00006_E8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	LUMICHROME	C12H10N4O2	CC1=CC2=C(C=C1C)N=C3C(=N2)C(=O)NC(=O)N3		Commercial		1086-80-2	2
GNPS00006_E9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	THYMIDINE	C10H14N2O5	CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O		Commercial		50-89-5	2
GNPS00006_E10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	CYTIDINE	C9H13N3O5	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		Commercial		65-46-3	2
GNPS00006_E11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	URIDINE	C9H12N2O6	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O		Commercial		58-96-8	2
GNPS00006_E12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	N1-ACETYLSPERMINE	C12H28N4O	CC(=O)NCCCNCCCCNCCCN		Commercial		77928-70-2	2
GNPS00006_F1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	ISOPENTENYL PYROPHOSPHATE	C5H12O7P2	CC(=C)CCOP(O)(=O)OP(O)(O)=O		Commercial		116057-53-5	0
GNPS00006_F2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	GAMMA,GAMMA-DIMETHYLALLYL PYROPHOSPHATE	C5H12O7P2	C/C(C)=C\COP(O)(OP(O)(O)=O)=O		Commercial		1186-30-7	0
GNPS00006_F3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	N-ACETYLTRYPTOPHAN	C13H14N2O3	CC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O		Commercial		87-32-1	3
GNPS00006_F4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	PYRIDOXAL-PHOSPHATE	C8H10NO6P	CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O		Commercial		853645-22-4	0
GNPS00006_F5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	SELENOCYSTAMINE	C4H12N2Se2	C(C[Se][Se]CCN)N		Commercial		3542-13-0	1
GNPS00006_F6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	5'-DEOXYADENOSINE	C10H13N5O3	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12		Commercial		4754-39-6	2
GNPS00006_F7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	DEOXYADENOSINE	C10H13N5O3	NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](CO)O1		Commercial		16373-93-6	2
GNPS00006_F8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	GLUCOSAMINE 6-SULFATE	C6H13NO8S	N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@@H](O)[C@@H]1O		Commercial		91674-26-9	3
GNPS00006_F9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	GLUCOSAMINE 6-PHOSPHATE	C6H14NO8P	N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O		Commercial		70442-23-8	4
GNPS00006_F10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	GLUCOSE 6-PHOSPHATE	C6H13O9P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		56-73-5	3
GNPS00006_F11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	GLUCOSE 6-PHOSPHATE	C6H13O9P	OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O		Commercial		103192-55-8	3
GNPS00006_F12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GALACTOSE 1-PHOSPHATE	C6H13O9P	OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O		Commercial		19046-60-7	1
GNPS00006_G1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	MANNOSE 6-PHOSPHATE	C6H13O9P	O[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O		Commercial		104872-94-8	1
GNPS00006_G2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	FRUCTOSE 6-PHOSPHATE	C6H13O9P	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O		Commercial		26177-86-6	1
GNPS00006_G3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	GLUCOSE 1-PHOSPHATE	C6H13O9P	OC[C@H]1OC(OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		56401-20-8	1
GNPS00006_G4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	THIAMINE	C12H17N4OS	CC1=C(CCO)SC=[N+]1CC1=C(N)N=C(C)N=C1		Commercial		67-03-8	0
GNPS00006_G5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	DEOXYGUANOSINE	C10H13N5O4	NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)N1		Commercial		961-07-9	3
GNPS00006_G6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	ADENOSINE	C10H13N5O4	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		Commercial		58-61-7	3
GNPS00006_G7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	HOMOCYSTINE	C8H16N2O4S2	NC(CCSSCCC(N)C(O)=O)C(O)=O		Commercial		462-10-2	2
GNPS00006_G8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	INOSINE	C10H12N4O5	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CNC2=O		Commercial		58-63-9	3
GNPS00006_G9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	GLUTARYLCARNITINE	C12H21NO6	C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CCCC(O)=O		Commercial		102636-82-8	0
GNPS00006_G10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	6-PHOSPHOGLUCONATE	C6H13O10P	O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O		Commercial		53411-70-4	2
GNPS00006_G11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	1-METHYLADENOSINE	C11H15N5O4	CN1C=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1=N		Commercial		15763-06-1	3
GNPS00006_G12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	GUANOSINE	C10H13N5O5	NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1		Commercial		118-00-3	3
GNPS00006_H1_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	XANTHOSINE	C10H12N4O6	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(O)N=C2O		Commercial		5968-90-1	2
GNPS00006_H2_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	OPHTHALMATE	C11H19N3O6	CC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O		Commercial		495-27-2	3
GNPS00006_H3_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	METHYLTHIOADENOSINE	C11H15N5O3S	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N		Commercial		2457-80-9	3
GNPS00006_H4_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H4	CYTIDINE 2',3'-CYCLIC PHOSPHATE	C9H12N3O7P	NC1=NC(=O)N(C=C1)C1O[C@H](CO)[C@H]2OP(O)(=O)O[C@@H]12		Commercial		15718-51-1	3
GNPS00006_H5_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H5	DEOXYCYTIDINE MONOPHOSPHATE	C9H14N3O7P	NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1		Commercial		1032-65-1	3
GNPS00006_H6_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H6	GLUTATHIONE REDUCED	C10H17N3O6S	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O		Commercial		70-18-8	3
GNPS00006_H7_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H7	DEOXYURIDINE-MONOPHOSPHATE	C9H13N2O8P	C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)O)O		Commercial		42155-08-8	2
GNPS00006_H8_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H8	N-ACETYLNEURAMINATE	C11H19NO9	CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O		Commercial		131-48-6	5
GNPS00006_H9_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H9	RIBOSE 1,5-BISPHOSPHATE	C5H12O11P2	O[C@H]1[C@@H](O)[C@@H](OP(O)(O)=O)O[C@@H]1COP(O)(O)=O		Commercial		14689-84-0	0
GNPS00006_H10_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H10	MELANIN	C18H10N2O4	CC1=C2NC=C3C2=C(C2=CNC4=C(C)C(=O)C(=O)C3=C24)C(=O)C1=O		Commercial		8049-97-6	0
GNPS00006_H11_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H11	THYMIDINE-MONOPHOSPHATE	C10H15N2O8P	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O		Commercial		33430-62-5	4
GNPS00006_H12_n.mzXML	GNPS00006	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H12	THYMIDINE-MONOPHOSPHATE	C10H15N2O8P	CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O		Commercial		365-07-1	4
__n.mzXML																		0
GNPS00005_A2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	3,4-DIHYDROXYBENZOATE	C7H6O4	OC(=O)C1=CC(O)=C(O)C=C1		Commercial		99-50-3	1
GNPS00005_A3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	HISTIDINE	C6H9N3O2	N[C@@H](CC1=CNC=N1)C(O)=O		Commercial		5934-29-2	9
GNPS00005_A4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	HISTIDINE	C6H9N3O2	N[C@@H](CC1=CNC=N1)C(O)=O		Commercial		71-00-1	9
GNPS00005_A5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	OROTATE	C5H4N2O4	OC(=O)C1=CC(=O)NC(=O)N1		Commercial		65-86-1	3
GNPS00005_A6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	OROTATE	C5H4N2O4	OC(=O)C1=CC(=O)NC(=O)N1		Commercial		50887-69-9	3
GNPS00005_A7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	URACIL 5-CARBOXYLATE	C5H4N2O4	C1=C(C(=O)NC(=O)N1)C(=O)O		Commercial		23945-44-0	3
GNPS00005_A8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	N-ACETYLPROLINE	C7H11NO3	CC(=O)N1CCCC1C(=O)O		Commercial		68-95-1	4
GNPS00005_A9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	DIHYDROOROTATE	C5H6N2O4	OC(=O)C1CC(=O)NC(=O)N1		Commercial		5988-19-2	3
GNPS00005_A10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	ALLANTOIN	C4H6N4O3	NC(=O)NC1NC(=O)NC1=O		Commercial		97-59-6	2
GNPS00005_A11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	6-CARBOXYHEXANOATE	C7H12O4	C(CCC(=O)O)CCC(=O)O		Commercial		111-16-0	1
GNPS00005_A12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	ETHYL 3-UREIDOPROPIONATE	C6H12N2O3	CCOC(=O)CCNC(=O)N		Commercial		198879-21-9	0
GNPS00005_B1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	TRYPTAMINE	C10H12N2	NCCC1=CNC2=CC=CC=C12		Commercial		61-54-1	1
GNPS00005_B2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	AMINOADIPATE	C6H11NO4	NC(CCCC(O)=O)C(O)=O		Commercial		542-32-5	3
GNPS00005_B3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	N-METHYLGLUTAMATE	C6H11NO4	CNC(CCC(=O)O)C(=O)O		Commercial		6753-62-4	3
GNPS00005_B4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	INDOLE-3-ETHANOL	C10H11NO	OCCC1=CNC2=CC=CC=C12		Commercial		526-55-6	3
GNPS00005_B5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	L-CARNITINE	C7H15NO3	C[N+](C)(C)C[C@H](O)CC([O-])=O		Commercial		6645-46-1	2
GNPS00005_B6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	NICOTINE	C10H14N2	CN1CCCC1C2=CN=CC=C2		Commercial		54-11-5	0
GNPS00005_B7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	3-HYDROXYMETHYLGLUTARATE	C6H10O5	CC(O)(CC(O)=O)CC(O)=O		Commercial		503-49-1	3
GNPS00005_B8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	5-HYDROXYLYSINE	C6H14N2O3	NC[C@H](O)CC[C@H](N)C(O)=O		Commercial		13204-98-3	3
GNPS00005_B9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	N-ACETYLCYSTEINE	C5H9NO3S	CC(=O)N[C@@H](CS)C(O)=O		Commercial		616-91-1	2
GNPS00005_B10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	PTERIN	C6H5N5O	NC1=NC2=NC=CN=C2C(=O)N1		Commercial		2236-60-4	2
GNPS00005_B11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	2,4-DIHYDROXYPTERIDINE	C6H4N4O2	C1=CN=C2C(=N1)C(=O)NC(=O)N2		Commercial		487-21-8	2
GNPS00005_B12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	2-DEOXY-D-GLUCOSE	C6H12O5	[H]C([H])(C=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO		Commercial		154-17-6	1
GNPS00005_C1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	FUCOSE	C6H12O5	C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O		Commercial		2438-80-4	2
GNPS00005_C2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	RHAMNOSE	C6H12O5	C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O		Commercial		10030-85-0	2
GNPS00005_C3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	PHENYLALANINE	C9H11NO2	N[C@@H](CC1=CC=CC=C1)C(O)=O		Commercial		63-91-2	2
GNPS00005_C4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	THIOPURINE S-METHYLETHER	C6H6N4S	CSC1=NC=NC2=C1NC=N2		Commercial		50-66-8	3
GNPS00005_C5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	3-(2-HYDROXYPHENYL)PROPANOATE	C9H10O3	OC(=O)CCC1=CC=CC=C1O		Commercial		495-78-3	1
GNPS00005_C6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	QUINOLINATE	C7H5NO4	OC(=O)C1=CC=CN=C1C(O)=O		Commercial		89-00-9	3
GNPS00005_C7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	4-HYDROXY-L-PHENYLGLYCINE	C8H9NO3	C1=CC(=CC=C1C(C(=O)O)N)O		Commercial		32462-30-9	1
GNPS00005_C8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	3-METHOXYTYRAMINE	C9H13NO2	COC1=C(O)C=CC(CCN)=C1		Commercial		1477-68-5	2
GNPS00005_C9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	PHOSPHOENOLPYRUVATE	C3H5O6P	OC(=O)C(=C)OP(O)(O)=O		Commercial		5541-93-5	1
GNPS00005_C10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	PHOSPHOENOLPYRUVATE	C3H5O6P	OC(=O)C(=C)OP(O)(O)=O		Commercial		4265-07-0	1
GNPS00005_C11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	URATE	C5H4N4O3	O=C1NC2=C(N1)C(=O)NC(=O)N2		Commercial		69-93-2	3
GNPS00005_C12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	3,4-DIHYDROXYPHENYLACETATE	C8H8O4	OC(=O)CC1=CC=C(O)C(O)=C1		Commercial		102-32-9	2
GNPS00005_D1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	PYRIDOXAMINE	C8H12N2O2	CC1=C(O)C(CN)=C(CO)C=N1		Commercial		524-36-7	3
GNPS00005_D2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	CYSTEATE	C3H7NO5S	NC(CS(O)(=O)=O)C(O)=O		Commercial		23537-25-9	2
GNPS00005_D3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	PYRIDOXINE	C8H11NO3	CC1=NC=C(CO)C(CO)=C1O		Commercial		65-23-6	5
GNPS00005_D4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	NORADRENALINE	C8H11NO3	NC[C@H](O)C1=CC(O)=C(O)C=C1		Commercial		51-41-2	3
GNPS00005_D5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	6-HYDROXYDOPAMINE	C8H11NO3	NCCC1=C(O)C=C(O)C(O)=C1		Commercial		28094-15-7	0
GNPS00005_D6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	1-METHYL-L-HISTIDINE	C7H11N3O2	CN1C=NC(C[C@H](N)C(O)=O)=C1		Commercial		332-80-9	3
GNPS00005_D7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	DIHYDROXYACETONE PHOSPHATE	C3H7O6P	OCC(=O)COP(O)(O)=O		Commercial		102783-56-2	0
GNPS00005_D8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	GLYCERALDEHYDE 3-PHOSPHATE	C3H7O6P	C(C(C=O)O)OP(=O)(O)O		Commercial		93965-35-6	0
GNPS00005_D9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	3,4-DIHYDROXYPHENYLGLYCOL	C8H10O4	OCC(O)C1=CC(O)=C(O)C=C1		Commercial		28822-73-3	4
GNPS00005_D10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	GLYCEROL 3-PHOSPHATE	C3H9O6P	OC[C@@H](O)COP(O)(O)=O		Commercial		29849-82-9	1
GNPS00005_D11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	BETA-GLYCEROPHOSPHATE	C3H9O6P	OCC(CO)OP(O)(O)=O		Commercial		154804-51-0	1
GNPS00005_D12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	3-DEHYDROSHIKIMATE	C7H8O5	C1C(C(C(=O)C=C1C(=O)O)O)O		Commercial		2922-42-1	3
GNPS00005_E1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	ANILINE-2-SULFONATE	C6H7NO3S	C1=CC=C(C(=C1)N)S(=O)(=O)O		Commercial		88-21-1	4
GNPS00005_E2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	2-QUINOLINECARBOXYLATE	C10H7NO2	OC(=O)C1=NC2=CC=CC=C2C=C1		Commercial		93-10-7	2
GNPS00005_E3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	TRANS-ACONITATE	C6H6O6	OC(=O)C\C(=C/C(O)=O)C(O)=O		Commercial		4023-65-8	0
GNPS00005_E4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	SHIKIMATE	C7H10O5	O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(O)=O		Commercial		138-59-0	2
GNPS00005_E5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	N-ACETYLASPARAGINE	C6H10N2O4	CC(=O)N[C@@H](CC(N)=O)C(O)=O		Commercial		4033-40-3	2
GNPS00005_E6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	INDOLE-3-ACETAMIDE	C10H10N2O	OC(=N)CC1=CNC2=CC=CC=C12		Commercial		879-37-8	3
GNPS00005_E7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	ARGININE	C6H14N4O2	N[C@@H](CCCN=C(N)N)C(O)=O		Commercial		1119-34-2	3
GNPS00005_E8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	N-METHYLTRYPTAMINE	C11H14N2	CNCCC1=CNC2=CC=CC=C12		Commercial		61-49-4	1
GNPS00005_E9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	N-ACETYLASPARTATE	C6H9NO5	CC(=O)N[C@@H](CC(O)=O)C(O)=O		Commercial		997-55-7	4
GNPS00005_E10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	GUANIDINOSUCCINATE	C5H9N3O4	NC(=N)N[C@@H](CC(O)=O)C(O)=O		Commercial		6133-30-8	2
GNPS00005_E11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	INDOLE-3-ACETATE	C10H9NO2	OC(=O)CC1=CNC2=C1C=CC=C2		Commercial		87-51-4	4
GNPS00005_E12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	INDOLE-3-ACETATE	C10H9NO2	OC(=O)CC1=CNC2=C1C=CC=C2		Commercial		6505-45-9	4
GNPS00005_F1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	CITRULLINE	C6H13N3O3	N[C@@H](CCCNC(N)=O)C(O)=O		Commercial		372-75-8	2
GNPS00005_F2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	ASCORBATE	C6H8O6	[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO		Commercial		50-81-7	0
GNPS00005_F3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	D-GLUCURONOLACTONE	C6H8O6	O[C@@H]1O[C@@H]2[C@@H](O)C(=O)O[C@@H]2[C@H]1O		Commercial		32449-92-6	1
GNPS00005_F4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	SEROTONIN	C10H12N2O	C1=CC2=C(C=C1O)C(=CN2)CCN		Commercial		61-47-2	2
GNPS00005_F5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	SEROTONIN	C10H12N2O	NCCC1=CNC2=CC=C(O)C=C12		Commercial		153-98-0	2
GNPS00005_F6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	N-FORMYL-L-METHIONINE	C6H11NO3S	CSCC[C@@H](NC=O)C(O)=O		Commercial		4289-98-9	3
GNPS00005_F7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	CYS-GLY	C5H10N2O3S	N[C@@H](CS)C(=O)NCC(O)=O		Commercial		19246-18-5	0
GNPS00005_F8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	GLUCONOLACTONE	C6H10O6	OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		90-80-2	0
GNPS00005_F9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	GLUCONOLACTONE	C6H10O6	CSC		Commercial		90-80-2	0
GNPS00005_F10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	S-CARBOXYMETHYLCYSTEINE	C5H9NO4S	NC(CSCC(O)=O)C(O)=O		Commercial		638-23-3	2
GNPS00005_F11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	HIPPURATE	C9H9NO3	OC(=O)CNC(=O)C1=CC=CC=C1		Commercial		495-69-2	3
GNPS00005_F12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GLUCOSAMINE	C6H13NO5	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		Commercial		66-84-2	3
GNPS00005_G1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	D-MANNOSAMINE	C6H13NO5	C(C1C(C(C(C(O1)O)N)O)O)O		Commercial		5505-63-5	7
GNPS00005_G2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	GALACTOSAMINE	C6H13NO5	C(C1C(C(C(C(O1)O)N)O)O)O		Commercial		1772-03-8	7
GNPS00005_G3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	CAFFEATE	C9H8O4	OC(=O)\C=C/C1=CC=C(O)C(O)=C1		Commercial		331-39-5	2
GNPS00005_G4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	3-(4-HYDROXYPHENYL)PYRUVATE	C9H8O4	OC(=O)C(=O)CC1=CC=C(O)C=C1		Commercial		156-39-8 	0
GNPS00005_G5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	METHIONINE SULFOXIMINE	C5H12N2O3S	CS(=N)(=O)CCC(N)C(O)=O		Commercial		15985-39-4	2
GNPS00005_G6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	THEOPHYLLINE	C7H8N4O2	CN1C2=C(NC=N2)C(=O)N(C)C1=O		Commercial		58-55-9	4
GNPS00005_G7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	PARAXANTHINE	C7H8N4O2	CN1C=NC2=C1C(=O)N(C)C(=O)N2		Commercial		611-59-6	1
GNPS00005_G8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	THEOBROMINE	C7H8N4O2	CN1C=NC2=C1C(=O)NC(=O)N2C		Commercial		83-67-0	1
GNPS00005_G9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	TYROSINE	C9H11NO3	N[C@@H](CC1=CC=C(O)C=C1)C(O)=O		Commercial		60-18-4	3
GNPS00005_G10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	METHYL VANILLATE	C9H10O4	COC1=C(C=CC(=C1)C(=O)OC)O		Commercial		3943-74-6	0
GNPS00005_G11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	GALACTITOL	C6H14O6	OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO		Commercial		608-66-2	2
GNPS00005_G12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	4-PYRIDOXATE	C8H9NO4	CC1=NC=C(CO)C(C(O)=O)=C1O		Commercial		82-82-6	6
GNPS00005_H1_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	PHOSPHORYLCHOLINE	C5H14NO4P	C[N+](C)(CCOP([O-])(O)=O)C		Commercial		72556-74-2	1
GNPS00005_H2_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	NORMETANEPHRINE	C9H13NO3	COC1=CC(=CC=C1O)C(O)CN		Commercial		1011-74-1	2
GNPS00005_H3_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	EPINEPHRINE	C9H13NO3	CNC[C@H](O)C1=CC=C(O)C(O)=C1		Commercial		51-43-4	3
GNPS00005_H4_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H4	3,4 DIHYDROXYMANDELATE	C8H8O5	OC(C(O)=O)C1=CC=C(O)C(O)=C1		Commercial		775-01-9	3
GNPS00005_H5_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H5	PHOSPHOSERINE	C3H8NO6P	N[C@@H](COP(O)(O)=O)C(O)=O		Commercial		407-41-0	1
GNPS00005_H6_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H6	O-PHOSPHOSERINE	C3H8NO6P	NC(COP(O)(O)=O)C(O)=O		Commercial		17885-08-4	1
GNPS00005_H7_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H7	2-PHOSPHOGLYCERATE	C3H7O7P	OCC(OP(O)(O)=O)C(O)=O		Commercial		2553-59-5	1
GNPS00005_H8_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H8	3-PHOSPHOGLYCERATE	C3H7O7P	OC(COP(O)(O)=O)C(O)=O		Commercial		80731-10-8	1
GNPS00005_H9_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H9	N-ALPHA-ACETYLLYSINE	C8H16N2O3	CC(=O)NC(CCCCN)C(O)=O		Commercial		1946-82-3	3
GNPS00005_H10_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H10	10-HYDROXYDECANOATE	C10H20O3	C(CCCCC(=O)O)CCCCO		Commercial		1679-53-4	3
GNPS00005_H11_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H11	N,N,N-TRIMETHYLLYSINE	C9H20N2O2	C[N+](C)(C)CCCC[C@H](N)C([O-])=O		Commercial		55528-53-5	1
GNPS00005_H12_p.mzXML	GNPS00005	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H12	KYNURENATE	C10H7NO3	OC(=O)C1=CC(=O)C2=CC=CC=C2N1		Commercial		492-27-3	2
GNPS00005_A1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A1	2,3-DIHYDROXYBENZOATE	C7H6O4	OC(=O)C1=CC=CC(O)=C1O		Commercial		303-38-8	2
GNPS00005_A2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A2	3,4-DIHYDROXYBENZOATE	C7H6O4	OC(=O)C1=CC(O)=C(O)C=C1		Commercial		99-50-3	1
GNPS00005_A3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A3	HISTIDINE	C6H9N3O2	N[C@@H](CC1=CNC=N1)C(O)=O		Commercial		5934-29-2	9
GNPS00005_A4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A4	HISTIDINE	C6H9N3O2	N[C@@H](CC1=CNC=N1)C(O)=O		Commercial		71-00-1	9
GNPS00005_A5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A5	OROTATE	C5H4N2O4	OC(=O)C1=CC(=O)NC(=O)N1		Commercial		65-86-1	3
GNPS00005_A6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A6	OROTATE	C5H4N2O4	OC(=O)C1=CC(=O)NC(=O)N1		Commercial		50887-69-9	3
GNPS00005_A7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A7	URACIL 5-CARBOXYLATE	C5H4N2O4	C1=C(C(=O)NC(=O)N1)C(=O)O		Commercial		23945-44-0	3
GNPS00005_A8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A8	N-ACETYLPROLINE	C7H11NO3	CC(=O)N1CCCC1C(=O)O		Commercial		68-95-1	4
GNPS00005_A9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A9	DIHYDROOROTATE	C5H6N2O4	OC(=O)C1CC(=O)NC(=O)N1		Commercial		5988-19-2	3
GNPS00005_A10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A10	ALLANTOIN	C4H6N4O3	NC(=O)NC1NC(=O)NC1=O		Commercial		97-59-6	2
GNPS00005_A11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A11	6-CARBOXYHEXANOATE	C7H12O4	C(CCC(=O)O)CCC(=O)O		Commercial		111-16-0	1
GNPS00005_A12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	A12	ETHYL 3-UREIDOPROPIONATE	C6H12N2O3	CCOC(=O)CCNC(=O)N		Commercial		198879-21-9	0
GNPS00005_B1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B1	TRYPTAMINE	C10H12N2	NCCC1=CNC2=CC=CC=C12		Commercial		61-54-1	1
GNPS00005_B2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B2	AMINOADIPATE	C6H11NO4	NC(CCCC(O)=O)C(O)=O		Commercial		542-32-5	3
GNPS00005_B3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B3	N-METHYLGLUTAMATE	C6H11NO4	CNC(CCC(=O)O)C(=O)O		Commercial		6753-62-4	3
GNPS00005_B4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B4	INDOLE-3-ETHANOL	C10H11NO	OCCC1=CNC2=CC=CC=C12		Commercial		526-55-6	3
GNPS00005_B5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B5	L-CARNITINE	C7H15NO3	C[N+](C)(C)C[C@H](O)CC([O-])=O		Commercial		6645-46-1	2
GNPS00005_B6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B6	NICOTINE	C10H14N2	CN1CCCC1C2=CN=CC=C2		Commercial		54-11-5	0
GNPS00005_B7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B7	3-HYDROXYMETHYLGLUTARATE	C6H10O5	CC(O)(CC(O)=O)CC(O)=O		Commercial		503-49-1	3
GNPS00005_B8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B8	5-HYDROXYLYSINE	C6H14N2O3	NC[C@H](O)CC[C@H](N)C(O)=O		Commercial		13204-98-3	3
GNPS00005_B9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B9	N-ACETYLCYSTEINE	C5H9NO3S	CC(=O)N[C@@H](CS)C(O)=O		Commercial		616-91-1	2
GNPS00005_B10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B10	PTERIN	C6H5N5O	NC1=NC2=NC=CN=C2C(=O)N1		Commercial		2236-60-4	2
GNPS00005_B11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B11	2,4-DIHYDROXYPTERIDINE	C6H4N4O2	C1=CN=C2C(=N1)C(=O)NC(=O)N2		Commercial		487-21-8	2
GNPS00005_B12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	B12	2-DEOXY-D-GLUCOSE	C6H12O5	[H]C([H])(C=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO		Commercial		154-17-6	1
GNPS00005_C1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C1	FUCOSE	C6H12O5	C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O		Commercial		2438-80-4	2
GNPS00005_C2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C2	RHAMNOSE	C6H12O5	C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O		Commercial		10030-85-0	2
GNPS00005_C3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C3	PHENYLALANINE	C9H11NO2	N[C@@H](CC1=CC=CC=C1)C(O)=O		Commercial		63-91-2	2
GNPS00005_C4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C4	THIOPURINE S-METHYLETHER	C6H6N4S	CSC1=NC=NC2=C1NC=N2		Commercial		50-66-8	3
GNPS00005_C5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C5	3-(2-HYDROXYPHENYL)PROPANOATE	C9H10O3	OC(=O)CCC1=CC=CC=C1O		Commercial		495-78-3	1
GNPS00005_C6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C6	QUINOLINATE	C7H5NO4	OC(=O)C1=CC=CN=C1C(O)=O		Commercial		89-00-9	3
GNPS00005_C7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C7	4-HYDROXY-L-PHENYLGLYCINE	C8H9NO3	C1=CC(=CC=C1C(C(=O)O)N)O		Commercial		32462-30-9	1
GNPS00005_C8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C8	3-METHOXYTYRAMINE	C9H13NO2	COC1=C(O)C=CC(CCN)=C1		Commercial		1477-68-5	2
GNPS00005_C9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C9	PHOSPHOENOLPYRUVATE	C3H5O6P	OC(=O)C(=C)OP(O)(O)=O		Commercial		5541-93-5	1
GNPS00005_C10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C10	PHOSPHOENOLPYRUVATE	C3H5O6P	OC(=O)C(=C)OP(O)(O)=O		Commercial		4265-07-0	1
GNPS00005_C11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C11	URATE	C5H4N4O3	O=C1NC2=C(N1)C(=O)NC(=O)N2		Commercial		69-93-2	3
GNPS00005_C12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	C12	3,4-DIHYDROXYPHENYLACETATE	C8H8O4	OC(=O)CC1=CC=C(O)C(O)=C1		Commercial		102-32-9	2
GNPS00005_D1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D1	PYRIDOXAMINE	C8H12N2O2	CC1=C(O)C(CN)=C(CO)C=N1		Commercial		524-36-7	3
GNPS00005_D2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D2	CYSTEATE	C3H7NO5S	NC(CS(O)(=O)=O)C(O)=O		Commercial		23537-25-9	2
GNPS00005_D3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D3	PYRIDOXINE	C8H11NO3	CC1=NC=C(CO)C(CO)=C1O		Commercial		65-23-6	5
GNPS00005_D4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D4	NORADRENALINE	C8H11NO3	NC[C@H](O)C1=CC(O)=C(O)C=C1		Commercial		51-41-2	3
GNPS00005_D5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D5	6-HYDROXYDOPAMINE	C8H11NO3	NCCC1=C(O)C=C(O)C(O)=C1		Commercial		28094-15-7	0
GNPS00005_D6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D6	1-METHYL-L-HISTIDINE	C7H11N3O2	CN1C=NC(C[C@H](N)C(O)=O)=C1		Commercial		332-80-9	3
GNPS00005_D7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D7	DIHYDROXYACETONE PHOSPHATE	C3H7O6P	OCC(=O)COP(O)(O)=O		Commercial		102783-56-2	0
GNPS00005_D8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D8	GLYCERALDEHYDE 3-PHOSPHATE	C3H7O6P	C(C(C=O)O)OP(=O)(O)O		Commercial		93965-35-6	0
GNPS00005_D9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D9	3,4-DIHYDROXYPHENYLGLYCOL	C8H10O4	OCC(O)C1=CC(O)=C(O)C=C1		Commercial		28822-73-3	4
GNPS00005_D10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D10	GLYCEROL 3-PHOSPHATE	C3H9O6P	OC[C@@H](O)COP(O)(O)=O		Commercial		29849-82-9	1
GNPS00005_D11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D11	BETA-GLYCEROPHOSPHATE	C3H9O6P	OCC(CO)OP(O)(O)=O		Commercial		154804-51-0	1
GNPS00005_D12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	D12	3-DEHYDROSHIKIMATE	C7H8O5	C1C(C(C(=O)C=C1C(=O)O)O)O		Commercial		2922-42-1	3
GNPS00005_E1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E1	ANILINE-2-SULFONATE	C6H7NO3S	C1=CC=C(C(=C1)N)S(=O)(=O)O		Commercial		88-21-1	4
GNPS00005_E2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E2	2-QUINOLINECARBOXYLATE	C10H7NO2	OC(=O)C1=NC2=CC=CC=C2C=C1		Commercial		93-10-7	2
GNPS00005_E3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E3	TRANS-ACONITATE	C6H6O6	OC(=O)C\C(=C/C(O)=O)C(O)=O		Commercial		4023-65-8	0
GNPS00005_E4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E4	SHIKIMATE	C7H10O5	O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(O)=O		Commercial		138-59-0	2
GNPS00005_E5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E5	N-ACETYLASPARAGINE	C6H10N2O4	CC(=O)N[C@@H](CC(N)=O)C(O)=O		Commercial		4033-40-3	2
GNPS00005_E6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E6	INDOLE-3-ACETAMIDE	C10H10N2O	OC(=N)CC1=CNC2=CC=CC=C12		Commercial		879-37-8	3
GNPS00005_E7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E7	ARGININE	C6H14N4O2	N[C@@H](CCCN=C(N)N)C(O)=O		Commercial		1119-34-2	3
GNPS00005_E8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E8	N-METHYLTRYPTAMINE	C11H14N2	CNCCC1=CNC2=CC=CC=C12		Commercial		61-49-4	1
GNPS00005_E9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E9	N-ACETYLASPARTATE	C6H9NO5	CC(=O)N[C@@H](CC(O)=O)C(O)=O		Commercial		997-55-7	4
GNPS00005_E10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E10	GUANIDINOSUCCINATE	C5H9N3O4	NC(=N)N[C@@H](CC(O)=O)C(O)=O		Commercial		6133-30-8	2
GNPS00005_E11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E11	INDOLE-3-ACETATE	C10H9NO2	OC(=O)CC1=CNC2=C1C=CC=C2		Commercial		87-51-4	4
GNPS00005_E12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	E12	INDOLE-3-ACETATE	C10H9NO2	OC(=O)CC1=CNC2=C1C=CC=C2		Commercial		6505-45-9	4
GNPS00005_F1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F1	CITRULLINE	C6H13N3O3	N[C@@H](CCCNC(N)=O)C(O)=O		Commercial		372-75-8	2
GNPS00005_F2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F2	ASCORBATE	C6H8O6	[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO		Commercial		50-81-7	0
GNPS00005_F3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F3	D-GLUCURONOLACTONE	C6H8O6	O[C@@H]1O[C@@H]2[C@@H](O)C(=O)O[C@@H]2[C@H]1O		Commercial		32449-92-6	1
GNPS00005_F4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F4	SEROTONIN	C10H12N2O	C1=CC2=C(C=C1O)C(=CN2)CCN		Commercial		61-47-2	2
GNPS00005_F5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F5	SEROTONIN	C10H12N2O	NCCC1=CNC2=CC=C(O)C=C12		Commercial		153-98-0	2
GNPS00005_F6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F6	N-FORMYL-L-METHIONINE	C6H11NO3S	CSCC[C@@H](NC=O)C(O)=O		Commercial		4289-98-9	3
GNPS00005_F7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F7	CYS-GLY	C5H10N2O3S	N[C@@H](CS)C(=O)NCC(O)=O		Commercial		19246-18-5	0
GNPS00005_F8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F8	GLUCONOLACTONE	C6H10O6	OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O		Commercial		90-80-2	0
GNPS00005_F9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F9	GLUCONOLACTONE	C6H10O6	CSC		Commercial		90-80-2	0
GNPS00005_F10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F10	S-CARBOXYMETHYLCYSTEINE	C5H9NO4S	NC(CSCC(O)=O)C(O)=O		Commercial		638-23-3	2
GNPS00005_F11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F11	HIPPURATE	C9H9NO3	OC(=O)CNC(=O)C1=CC=CC=C1		Commercial		495-69-2	3
GNPS00005_F12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	F12	GLUCOSAMINE	C6H13NO5	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		Commercial		66-84-2	3
GNPS00005_G1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G1	D-MANNOSAMINE	C6H13NO5	C(C1C(C(C(C(O1)O)N)O)O)O		Commercial		5505-63-5	7
GNPS00005_G2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G2	GALACTOSAMINE	C6H13NO5	C(C1C(C(C(C(O1)O)N)O)O)O		Commercial		1772-03-8	7
GNPS00005_G3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G3	CAFFEATE	C9H8O4	OC(=O)\C=C/C1=CC=C(O)C(O)=C1		Commercial		331-39-5	2
GNPS00005_G4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G4	3-(4-HYDROXYPHENYL)PYRUVATE	C9H8O4	OC(=O)C(=O)CC1=CC=C(O)C=C1		Commercial		156-39-8 	0
GNPS00005_G5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G5	METHIONINE SULFOXIMINE	C5H12N2O3S	CS(=N)(=O)CCC(N)C(O)=O		Commercial		15985-39-4	2
GNPS00005_G6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G6	THEOPHYLLINE	C7H8N4O2	CN1C2=C(NC=N2)C(=O)N(C)C1=O		Commercial		58-55-9	4
GNPS00005_G7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G7	PARAXANTHINE	C7H8N4O2	CN1C=NC2=C1C(=O)N(C)C(=O)N2		Commercial		611-59-6	1
GNPS00005_G8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G8	THEOBROMINE	C7H8N4O2	CN1C=NC2=C1C(=O)NC(=O)N2C		Commercial		83-67-0	1
GNPS00005_G9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G9	TYROSINE	C9H11NO3	N[C@@H](CC1=CC=C(O)C=C1)C(O)=O		Commercial		60-18-4	3
GNPS00005_G10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G10	METHYL VANILLATE	C9H10O4	COC1=C(C=CC(=C1)C(=O)OC)O		Commercial		3943-74-6	0
GNPS00005_G11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G11	GALACTITOL	C6H14O6	OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO		Commercial		608-66-2	2
GNPS00005_G12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	G12	4-PYRIDOXATE	C8H9NO4	CC1=NC=C(CO)C(C(O)=O)=C1O		Commercial		82-82-6	6
GNPS00005_H1_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H1	PHOSPHORYLCHOLINE	C5H14NO4P	C[N+](C)(CCOP([O-])(O)=O)C		Commercial		72556-74-2	1
GNPS00005_H2_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H2	NORMETANEPHRINE	C9H13NO3	COC1=CC(=CC=C1O)C(O)CN		Commercial		1011-74-1	2
GNPS00005_H3_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H3	EPINEPHRINE	C9H13NO3	CNC[C@H](O)C1=CC=C(O)C(O)=C1		Commercial		51-43-4	3
GNPS00005_H4_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H4	3,4 DIHYDROXYMANDELATE	C8H8O5	OC(C(O)=O)C1=CC=C(O)C(O)=C1		Commercial		775-01-9	3
GNPS00005_H5_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H5	PHOSPHOSERINE	C3H8NO6P	N[C@@H](COP(O)(O)=O)C(O)=O		Commercial		407-41-0	1
GNPS00005_H6_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H6	O-PHOSPHOSERINE	C3H8NO6P	NC(COP(O)(O)=O)C(O)=O		Commercial		17885-08-4	1
GNPS00005_H7_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H7	2-PHOSPHOGLYCERATE	C3H7O7P	OCC(OP(O)(O)=O)C(O)=O		Commercial		2553-59-5	1
GNPS00005_H8_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H8	3-PHOSPHOGLYCERATE	C3H7O7P	OC(COP(O)(O)=O)C(O)=O		Commercial		80731-10-8	1
GNPS00005_H9_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H9	N-ALPHA-ACETYLLYSINE	C8H16N2O3	CC(=O)NC(CCCCN)C(O)=O		Commercial		1946-82-3	3
GNPS00005_H10_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H10	10-HYDROXYDECANOATE	C10H20O3	C(CCCCC(=O)O)CCCCO		Commercial		1679-53-4	3
GNPS00005_H11_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H11	N,N,N-TRIMETHYLLYSINE	C9H20N2O2	C[N+](C)(C)CCCC[C@H](N)C([O-])=O		Commercial		55528-53-5	1
GNPS00005_H12_n.mzXML	GNPS00005	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191009.0	H12	KYNURENATE	C10H7NO3	OC(=O)C1=CC(=O)C2=CC=CC=C2N1		Commercial		492-27-3	2
__n.mzXML																		0
GNPS00004_A2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A2	NICOTINAMIDE	C6H6N2O	NC(=O)C1=CN=CC=C1		Commercial		98-92-0	1
GNPS00004_A3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A3	ERYTHRITOL	C4H10O4	OC[C@H](O)[C@H](O)CO		Commercial		149-32-6	1
GNPS00004_A4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A4	NICOTINATE	C6H5NO2	OC(=O)C1=CN=CC=C1		Commercial		59-67-6	2
GNPS00004_A5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A5	PICOLINATE	C6H5NO2	OC(=O)C1=CC=CC=N1		Commercial		98-98-6	0
GNPS00004_A6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A6	3-HYDROXYBENZYL ALCOHOL	C7H8O2	OCC1=CC=CC(O)=C1		Commercial		620-24-6	0
GNPS00004_A7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A7	GUAIACOL	C7H8O2	COC1=CC=CC=C1O		Commercial		90-05-1	0
GNPS00004_A8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A8	TAURINE	C2H7NO3S	NCCS(O)(=O)=O		Commercial		107-35-7	1
GNPS00004_A9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A9	(2-AMINOETHYL)PHOSPHONATE	C2H8NO3P	NCCP(O)(O)=O		Commercial		2041-14-7	1
GNPS00004_A10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A10	5-METHYLCYTOSINE	C5H7N3O	CC1=C(N)NC(=O)N=C1		Commercial		58366-64-6	4
GNPS00004_A11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A11	3-METHYLHISTAMINE	C6H11N3	CN1C=NC=C1CCN		Commercial		36475-47-5	1
GNPS00004_A12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A12	THYMINE	C5H6N2O2	CC1=CNC(=O)NC1=O		Commercial		65-71-4	0
GNPS00004_B1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B1	4-IMIDAZOLEACETATE	C5H6N2O2	OC(=O)CC1=CN=CN1		Commercial		3251-69-2	1
GNPS00004_B2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B2	OXOPROLINE	C5H7NO3	OC(=O)C1CCC(=O)N1		Commercial		4042-36-8	3
GNPS00004_B3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B3	PYROGLUTAMATE	C5H7NO3	OC(=O)[C@@H]1CCC(=O)N1		Commercial		98-79-3	3
GNPS00004_B4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B4	PIPECOLATE	C6H11NO2	OC(=O)C1CCCCN1		Commercial		535-75-1	2
GNPS00004_B5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B5	PIPECOLATE	C6H11NO2	OC(=O)[C@@H]1CCCCN1		Commercial		3105-95-1	3
GNPS00004_B6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B6	MEVALOLACTONE	C6H10O3	C[C@]1(O)CCOC(=O)C1		Commercial		674-26-0	1
GNPS00004_B7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B7	PANTOLACTONE	C6H10O3	CC1(C)COC(=O)C1O		Commercial		0599-04-02	1
GNPS00004_B8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B8	N-ACETYLPUTRESCINE	C6H14N2O	CC(=O)NCCCCN		Commercial		18233-70-0	2
GNPS00004_B9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B9	AGMATINE SULFATE	C5H14N4	C(CCN=C(N)N)CN		Commercial		2482-00-0	1
GNPS00004_B10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B10	TRANS-4-HYDROXY-L-PROLINE	C5H9NO3	O[C@H]1CN[C@@H](C1)C(O)=O		Commercial		51-35-4	3
GNPS00004_B11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B11	TRANS-4-HYDROXY-L-PROLINE	C5H9NO3	OC1CN[C@@H](C1)C(O)=O		Commercial		51-35-4	3
GNPS00004_B12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B12	5-AMINOLEVULINATE	C5H9NO3	NCC(=O)CCC(O)=O		Commercial		5451-09-02	3
GNPS00004_C1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C1	N-ACETYLALANINE	C5H9NO3	C[C@H](NC(C)=O)C(O)=O		Commercial		97-69-8	2
GNPS00004_C2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C2	CIS-4-HYDROXY-D-PROLINE	C5H9NO3	O[C@H]1CN[C@H](C1)C(O)=O		Commercial		2584-71-6	2
GNPS00004_C3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C3	CREATINE	C4H9N3O2	CN(CC(O)=O)C(N)=N		Commercial		57-00-1	3
GNPS00004_C4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C4	ISOLEUCINE	C6H13NO2	CC[C@H](C)[C@H](N)C(O)=O		Commercial		73-32-5	2
GNPS00004_C5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C5	LEUCINE	C6H13NO2	CC(C)C[C@H](N)C(O)=O		Commercial		328-39-2	2
GNPS00004_C6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C6	NORLEUCINE	C6H13NO2	CCCC[C@H](N)C(O)=O		Commercial		327-57-1	2
GNPS00004_C7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C7	NORSPERMIDINE	C6H17N3	NCCCNCCCN		Commercial		56-18-8	1
GNPS00004_C8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C8	OXALOACETATE	C4H4O5	OC(=O)CC(=O)C(O)=O		Commercial		328-42-7	0
GNPS00004_C9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C9	GLUTARATE	C5H8O4	OC(=O)CCCC(O)=O		Commercial		110-94-1	4
GNPS00004_C10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C10	MONOETHYLMALONATE	C5H8O4	CCOC(=O)CC(O)=O		Commercial		1071-46-1	0
GNPS00004_C11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C11	GLUTARATE	C5H8O4	OC(=O)CCCC(O)=O		Commercial		110-94-1	4
GNPS00004_C12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C12	ETHYLMALONATE	C5H8O4	CCC(C(O)=O)C(O)=O		Commercial		601-75-2	1
GNPS00004_D1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D1	ASPARAGINE	C4H8N2O3	N[C@@H](CC(N)=O)C(O)=O		Commercial		70-47-3	3
GNPS00004_D2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D2	UREIDOPROPIONATE	C4H8N2O3	NC(=O)NCCC(O)=O		Commercial		462-88-4	2
GNPS00004_D3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D3	D-ORNITHINE	C5H12N2O2	NCCC[C@@H](N)C(O)=O		Commercial		16682-12-5	0
GNPS00004_D4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D4	L-ORNITHINE	C5H12N2O2	NCCC[C@H](N)C(O)=O		Commercial		3184-13-2	2
GNPS00004_D5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D5	ASPARTATE	C4H7NO4	N[C@H](CC(O)=O)C(O)=O		Commercial		1783-96-6	2
GNPS00004_D6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D6	ASPARTATE	C4H7NO4	N[C@@H](CC(O)=O)C(O)=O		Commercial		56-84-8	2
GNPS00004_D7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D7	MALATE	C4H6O5	O[C@@H](CC(O)=O)C(O)=O		Commercial		97-67-6	2
GNPS00004_D8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D8	MALATE	C4H6O5	O[C@H](CC(O)=O)C(O)=O		Commercial		636-61-3	1
GNPS00004_D9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D9	DEOXYRIBOSE	C5H10O4	OC[C@@H]1O[C@H](O)C[C@H]1O		Commercial		533-67-5	0
GNPS00004_D10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D10	HOMOCYSTEINE	C4H9NO2S	NC(CCS)C(O)=O		Commercial		454-29-5	2
GNPS00004_D11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D11	ADENINE	C5H5N5	NC1=NC=NC2=C1NC=N2		Commercial		73-24-5	8
GNPS00004_D12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D12	ADENINE	C5H5N5	NC1=NC=NC2=C1NC=N2		Commercial		2922-28-3 (ANHYDROUS)	8
GNPS00004_E1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E1	HYPOXANTHINE	C5H4N4O	OC1=NC=NC2=C1NC=N2		Commercial		68-94-0	3
GNPS00004_E2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E2	TRIGONELLINE	C7H7NO2	C[N+]1=CC(=CC=C1)C([O-])=O		Commercial		6138-41-6	3
GNPS00004_E3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E3	4-AMINOBENZOATE	C7H7NO2	NC1=CC=C(C=C1)C(O)=O		Commercial		150-13-0	2
GNPS00004_E4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E4	ANTHRANILATE	C7H7NO2	NC1=CC=CC=C1C(O)=O		Commercial		118-92-3	3
GNPS00004_E5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E5	1-METHYLNICOTINAMIDE	C7H9N2O	C[N+]1=CC=CC(=C1)C(N)=O		Commercial		1005-24-9	0
GNPS00004_E6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E6	TYRAMINE	C8H11NO	NCCC1=CC=C(O)C=C1		Commercial		51-67-2	1
GNPS00004_E7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E7	PHENYLETHANOLAMINE	C8H11NO	NCC(O)C1=CC=CC=C1		Commercial		7568-93-6	1
GNPS00004_E8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E8	4-HYDROXYBENZOATE	C7H6O3	OC(=O)C1=CC=C(O)C=C1		Commercial		99-96-7	1
GNPS00004_E9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E9	UROCANATE	C6H6N2O2	OC(=O)\C=C\C1=CNC=N1		Commercial		104-98-3	3
GNPS00004_E10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E10	6-HYDROXYNICOTINATE	C6H5NO3	OC(=O)C1=CN=C(O)C=C1		Commercial		5006-66-6	2
GNPS00004_E11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E11	PHOSPHONOACETATE	C2H5O5P	OC(=O)CP(O)(O)=O		Commercial		4408-78-0	0
GNPS00004_E12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E12	CARBAMOYL PHOSPHATE	CH4NO5P	NC(=O)OP(O)(O)=O		Commercial		72461-86-0	0
GNPS00004_F1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F1	CARBAMOYL PHOSPHATE	CH4NO5P	NC(=O)OP(O)(O)=O		Commercial		1866-68-8 (anhydrous)	0
GNPS00004_F2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F2	ETHANOLAMINE PHOSPHATE	C2H8NO4P	NCCOP(O)(O)=O		Commercial		1071-23-4	2
GNPS00004_F3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F3	O-PHOSPHOETHANOLAMINE	C2H8NO4P	NCCOP(O)(O)=O		Commercial		1071-23-4	2
GNPS00004_F4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F4	HISTIDINOL	C6H11N3O	N[C@H](CO)CC1=CN=CN1		Commercial		1596-64-1	4
GNPS00004_F5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F5	4-ACETAMIDOBUTANOATE	C6H11NO3	CC(=O)NCCCC(O)=O		Commercial		3025-96-5	3
GNPS00004_F6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F6	4-GUANIDINOBUTANOATE	C5H11N3O2	NC(N)=NCCCC(O)=O		Commercial		463-00-3	3
GNPS00004_F7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F7	DEOXYCARNITINE	C7H15NO2	C[N+](C)(CCCC([O-])=O)C		Commercial		6249-56-5	1
GNPS00004_F8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F8	SPERMIDINE	C7H19N3	NCCCCNCCCN		Commercial		334-50-9	2
GNPS00004_F9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F9	SPERMIDINE	C7H19N3	NCCCCNCCCN		Commercial		124-20-9	2
GNPS00004_F10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F10	METHYGLUTARATE	C6H10O4	CC(CC(O)=O)CC(O)=O		Commercial		626-51-7	2
GNPS00004_F11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F11	GLUTAMINE	C5H10N2O3	N[C@@H](CCC(N)=O)C(O)=O		Commercial		56-85-9	2
GNPS00004_F12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F12	LYSINE	C6H14N2O2	NCCCC[C@H](N)C(O)=O		Commercial		56-87-1	4
GNPS00004_G1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G1	LYSINE	C6H14N2O2	NCCCC[C@H](N)C(O)=O		Commercial		657-27-2	4
GNPS00004_G2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G2	ACETYLCHOLINE	C7H16NO2	CC(=O)OCC[N+](C)(C)C		Commercial		60-31-1	0
GNPS00004_G3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G3	GLUTAMATE	C5H9NO4	N[C@@H](CCC(O)=O)C(O)=O		Commercial		56-86-0	2
GNPS00004_G4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G4	N-METHYLASPARTATE	C5H9NO4	CN[C@H](CC(O)=O)C(O)=O		Commercial		6384-92-5	2
GNPS00004_G5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G5	O-ACETYLSERINE	C5H9NO4	CC(=O)OC[C@H](N)C(O)=O		Commercial		66638-22-0	1
GNPS00004_G6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G6	N-ACETYLSERINE	C5H9NO4	CC(=O)N[C@@H](CO)C(O)=O		Commercial		97-14-3	2
GNPS00004_G7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G7	DIHYDROXYFUMARATE	C4H4O6	OC(O)=C(O)C(=O)C(O)=O		Commercial		199926-38-0	0
GNPS00004_G8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G8	CITRAMALATE	C5H8O5	CC(O)(CC(O)=O)C(O)=O		Commercial		1030365-02-6 (ANHYDROUS)	1
GNPS00004_G9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G9	METHIONINE	C5H11NO2S	CSCC[C@H](N)C(O)=O		Commercial		63-68-3	2
GNPS00004_G10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G10	TARTRATE	C4H6O6	O[C@H]([C@@H](O)C(O)=O)C(O)=O		Commercial		87-69-4	1
GNPS00004_G11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G11	TARTRATE	C4H6O6	O[C@@H]([C@H](O)C(O)=O)C(O)=O		Commercial		147-71-7	1
GNPS00004_G12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G12	MESO-TARTRATE	C4H606	C(C(C(=O)O)O)(C(=O)O)O.O		Commercial		5990-63-6	0
GNPS00004_H1_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H1	2-HYDROXY-4-(METHYLTHIO)BUTANOATE	C5H10O3S	CSCCC(O)C(O)=O		Commercial		4857-44-7	2
GNPS00004_H2_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H2	GUANINE	C5H5N5O	NC1=NC(=O)C2=C(N1)N=CN2		Commercial		73-40-5	3
GNPS00004_H3_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H3	XANTHINE	C5H4N4O2	O=C1NC2=C(NC=N2)C(=O)N1		Commercial		69-89-6	2
GNPS00004_H4_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H4	P-HYDROXYPHENYLACETATE	C8H8O3	NCCC(O)=O		Commercial		156-38-7	0
GNPS00004_H5_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H5	MANDELATE	C8H8O3	O[C@H](C(O)=O)C1=CC=CC=C1		Commercial		90-64-2	1
GNPS00004_H6_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H6	2-HYDROXYPHENYLACETATE	C8H8O3	OC(=O)CC1=CC=CC=C1O		Commercial		611-71-2	1
GNPS00004_H7_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H7	3-SULFINOALANINE	C3H7NO4S	N[C@@H](CS(=O)=O)C(O)=O		Commercial		207121-48-0	2
GNPS00004_H8_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H8	3-HYDROXYANTHRANILATE	C7H7NO3	NC1=C(O)C=CC=C1C(O)=O		Commercial		548-93-6	3
GNPS00004_H9_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H9	3-AMINO-5-HYDROXYBENZOATE	C7H7NO3	C1=C(C=C(C=C1N)O)C(=O)O		Commercial		76045-71-1	2
GNPS00004_H10_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H10	3-AMINO-4-HYDROXYBENZOATE	C7H7NO3	C1=CC(=C(C=C1C(=O)O)N)O		Commercial		1571-72-8	2
GNPS00004_H11_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H11	DOPAMINE	C8H11NO2	NCCC1=CC=C(O)C(O)=C1		Commercial		62-31-7	2
GNPS00004_H12_p.mzXML	GNPS00004	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H12	P-OCTOPAMINE	C8H11NO2	NC[C@H](O)C1=CC=C(O)C=C1		Commercial		0770-05-08	2
GNPS00004_A1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A1	3-HYDROXYBENZALDEHYDE	C7H6O2	C1=CC(=CC(=C1)O)C=O		Commercial		100-83-4	0
GNPS00004_A2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A2	NICOTINAMIDE	C6H6N2O	NC(=O)C1=CN=CC=C1		Commercial		98-92-0	1
GNPS00004_A3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A3	ERYTHRITOL	C4H10O4	OC[C@H](O)[C@H](O)CO		Commercial		149-32-6	1
GNPS00004_A4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A4	NICOTINATE	C6H5NO2	OC(=O)C1=CN=CC=C1		Commercial		59-67-6	2
GNPS00004_A5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A5	PICOLINATE	C6H5NO2	OC(=O)C1=CC=CC=N1		Commercial		98-98-6	0
GNPS00004_A6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A6	3-HYDROXYBENZYL ALCOHOL	C7H8O2	OCC1=CC=CC(O)=C1		Commercial		620-24-6	0
GNPS00004_A7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A7	GUAIACOL	C7H8O2	COC1=CC=CC=C1O		Commercial		90-05-1	0
GNPS00004_A8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A8	TAURINE	C2H7NO3S	NCCS(O)(=O)=O		Commercial		107-35-7	1
GNPS00004_A9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A9	(2-AMINOETHYL)PHOSPHONATE	C2H8NO3P	NCCP(O)(O)=O		Commercial		2041-14-7	1
GNPS00004_A10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A10	5-METHYLCYTOSINE	C5H7N3O	CC1=C(N)NC(=O)N=C1		Commercial		58366-64-6	4
GNPS00004_A11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A11	3-METHYLHISTAMINE	C6H11N3	CN1C=NC=C1CCN		Commercial		36475-47-5	1
GNPS00004_A12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A12	THYMINE	C5H6N2O2	CC1=CNC(=O)NC1=O		Commercial		65-71-4	0
GNPS00004_B1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B1	4-IMIDAZOLEACETATE	C5H6N2O2	OC(=O)CC1=CN=CN1		Commercial		3251-69-2	1
GNPS00004_B2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B2	OXOPROLINE	C5H7NO3	OC(=O)C1CCC(=O)N1		Commercial		4042-36-8	3
GNPS00004_B3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B3	PYROGLUTAMATE	C5H7NO3	OC(=O)[C@@H]1CCC(=O)N1		Commercial		98-79-3	3
GNPS00004_B4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B4	PIPECOLATE	C6H11NO2	OC(=O)C1CCCCN1		Commercial		535-75-1	2
GNPS00004_B5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B5	PIPECOLATE	C6H11NO2	OC(=O)[C@@H]1CCCCN1		Commercial		3105-95-1	3
GNPS00004_B6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B6	MEVALOLACTONE	C6H10O3	C[C@]1(O)CCOC(=O)C1		Commercial		674-26-0	1
GNPS00004_B7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B7	PANTOLACTONE	C6H10O3	CC1(C)COC(=O)C1O		Commercial		0599-04-02	1
GNPS00004_B8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B8	N-ACETYLPUTRESCINE	C6H14N2O	CC(=O)NCCCCN		Commercial		18233-70-0	2
GNPS00004_B9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B9	AGMATINE SULFATE	C5H14N4	C(CCN=C(N)N)CN		Commercial		2482-00-0	1
GNPS00004_B10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B10	TRANS-4-HYDROXY-L-PROLINE	C5H9NO3	O[C@H]1CN[C@@H](C1)C(O)=O		Commercial		51-35-4	3
GNPS00004_B11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B11	TRANS-4-HYDROXY-L-PROLINE	C5H9NO3	OC1CN[C@@H](C1)C(O)=O		Commercial		51-35-4	3
GNPS00004_B12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B12	5-AMINOLEVULINATE	C5H9NO3	NCC(=O)CCC(O)=O		Commercial		5451-09-02	3
GNPS00004_C1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C1	N-ACETYLALANINE	C5H9NO3	C[C@H](NC(C)=O)C(O)=O		Commercial		97-69-8	2
GNPS00004_C2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C2	CIS-4-HYDROXY-D-PROLINE	C5H9NO3	O[C@H]1CN[C@H](C1)C(O)=O		Commercial		2584-71-6	2
GNPS00004_C3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C3	CREATINE	C4H9N3O2	CN(CC(O)=O)C(N)=N		Commercial		57-00-1	3
GNPS00004_C4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C4	ISOLEUCINE	C6H13NO2	CC[C@H](C)[C@H](N)C(O)=O		Commercial		73-32-5	2
GNPS00004_C5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C5	LEUCINE	C6H13NO2	CC(C)C[C@H](N)C(O)=O		Commercial		328-39-2	2
GNPS00004_C6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C6	NORLEUCINE	C6H13NO2	CCCC[C@H](N)C(O)=O		Commercial		327-57-1	2
GNPS00004_C7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C7	NORSPERMIDINE	C6H17N3	NCCCNCCCN		Commercial		56-18-8	1
GNPS00004_C8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C8	OXALOACETATE	C4H4O5	OC(=O)CC(=O)C(O)=O		Commercial		328-42-7	0
GNPS00004_C9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C9	GLUTARATE	C5H8O4	OC(=O)CCCC(O)=O		Commercial		110-94-1	4
GNPS00004_C10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C10	MONOETHYLMALONATE	C5H8O4	CCOC(=O)CC(O)=O		Commercial		1071-46-1	0
GNPS00004_C11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C11	GLUTARATE	C5H8O4	OC(=O)CCCC(O)=O		Commercial		110-94-1	4
GNPS00004_C12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C12	ETHYLMALONATE	C5H8O4	CCC(C(O)=O)C(O)=O		Commercial		601-75-2	1
GNPS00004_D1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D1	ASPARAGINE	C4H8N2O3	N[C@@H](CC(N)=O)C(O)=O		Commercial		70-47-3	3
GNPS00004_D2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D2	UREIDOPROPIONATE	C4H8N2O3	NC(=O)NCCC(O)=O		Commercial		462-88-4	2
GNPS00004_D3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D3	D-ORNITHINE	C5H12N2O2	NCCC[C@@H](N)C(O)=O		Commercial		16682-12-5	0
GNPS00004_D4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D4	L-ORNITHINE	C5H12N2O2	NCCC[C@H](N)C(O)=O		Commercial		3184-13-2	2
GNPS00004_D5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D5	ASPARTATE	C4H7NO4	N[C@H](CC(O)=O)C(O)=O		Commercial		1783-96-6	2
GNPS00004_D6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D6	ASPARTATE	C4H7NO4	N[C@@H](CC(O)=O)C(O)=O		Commercial		56-84-8	2
GNPS00004_D7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D7	MALATE	C4H6O5	O[C@@H](CC(O)=O)C(O)=O		Commercial		97-67-6	2
GNPS00004_D8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D8	MALATE	C4H6O5	O[C@H](CC(O)=O)C(O)=O		Commercial		636-61-3	1
GNPS00004_D9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D9	DEOXYRIBOSE	C5H10O4	OC[C@@H]1O[C@H](O)C[C@H]1O		Commercial		533-67-5	0
GNPS00004_D10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D10	HOMOCYSTEINE	C4H9NO2S	NC(CCS)C(O)=O		Commercial		454-29-5	2
GNPS00004_D11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D11	ADENINE	C5H5N5	NC1=NC=NC2=C1NC=N2		Commercial		73-24-5	8
GNPS00004_D12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D12	ADENINE	C5H5N5	NC1=NC=NC2=C1NC=N2		Commercial		2922-28-3 (ANHYDROUS)	8
GNPS00004_E1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E1	HYPOXANTHINE	C5H4N4O	OC1=NC=NC2=C1NC=N2		Commercial		68-94-0	3
GNPS00004_E2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E2	TRIGONELLINE	C7H7NO2	C[N+]1=CC(=CC=C1)C([O-])=O		Commercial		6138-41-6	3
GNPS00004_E3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E3	4-AMINOBENZOATE	C7H7NO2	NC1=CC=C(C=C1)C(O)=O		Commercial		150-13-0	2
GNPS00004_E4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E4	ANTHRANILATE	C7H7NO2	NC1=CC=CC=C1C(O)=O		Commercial		118-92-3	3
GNPS00004_E5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E5	1-METHYLNICOTINAMIDE	C7H9N2O	C[N+]1=CC=CC(=C1)C(N)=O		Commercial		1005-24-9	0
GNPS00004_E6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E6	TYRAMINE	C8H11NO	NCCC1=CC=C(O)C=C1		Commercial		51-67-2	1
GNPS00004_E7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E7	PHENYLETHANOLAMINE	C8H11NO	NCC(O)C1=CC=CC=C1		Commercial		7568-93-6	1
GNPS00004_E8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E8	4-HYDROXYBENZOATE	C7H6O3	OC(=O)C1=CC=C(O)C=C1		Commercial		99-96-7	1
GNPS00004_E9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E9	UROCANATE	C6H6N2O2	OC(=O)\C=C\C1=CNC=N1		Commercial		104-98-3	3
GNPS00004_E10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E10	6-HYDROXYNICOTINATE	C6H5NO3	OC(=O)C1=CN=C(O)C=C1		Commercial		5006-66-6	2
GNPS00004_E11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E11	PHOSPHONOACETATE	C2H5O5P	OC(=O)CP(O)(O)=O		Commercial		4408-78-0	0
GNPS00004_E12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E12	CARBAMOYL PHOSPHATE	CH4NO5P	NC(=O)OP(O)(O)=O		Commercial		72461-86-0	0
GNPS00004_F1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F1	CARBAMOYL PHOSPHATE	CH4NO5P	NC(=O)OP(O)(O)=O		Commercial		1866-68-8 (anhydrous)	0
GNPS00004_F2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F2	ETHANOLAMINE PHOSPHATE	C2H8NO4P	NCCOP(O)(O)=O		Commercial		1071-23-4	2
GNPS00004_F3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F3	O-PHOSPHOETHANOLAMINE	C2H8NO4P	NCCOP(O)(O)=O		Commercial		1071-23-4	2
GNPS00004_F4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F4	HISTIDINOL	C6H11N3O	N[C@H](CO)CC1=CN=CN1		Commercial		1596-64-1	4
GNPS00004_F5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F5	4-ACETAMIDOBUTANOATE	C6H11NO3	CC(=O)NCCCC(O)=O		Commercial		3025-96-5	3
GNPS00004_F6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F6	4-GUANIDINOBUTANOATE	C5H11N3O2	NC(N)=NCCCC(O)=O		Commercial		463-00-3	3
GNPS00004_F7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F7	DEOXYCARNITINE	C7H15NO2	C[N+](C)(CCCC([O-])=O)C		Commercial		6249-56-5	1
GNPS00004_F8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F8	SPERMIDINE	C7H19N3	NCCCCNCCCN		Commercial		334-50-9	2
GNPS00004_F9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F9	SPERMIDINE	C7H19N3	NCCCCNCCCN		Commercial		124-20-9	2
GNPS00004_F10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F10	METHYGLUTARATE	C6H10O4	CC(CC(O)=O)CC(O)=O		Commercial		626-51-7	2
GNPS00004_F11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F11	GLUTAMINE	C5H10N2O3	N[C@@H](CCC(N)=O)C(O)=O		Commercial		56-85-9	2
GNPS00004_F12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F12	LYSINE	C6H14N2O2	NCCCC[C@H](N)C(O)=O		Commercial		56-87-1	4
GNPS00004_G1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G1	LYSINE	C6H14N2O2	NCCCC[C@H](N)C(O)=O		Commercial		657-27-2	4
GNPS00004_G2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G2	ACETYLCHOLINE	C7H16NO2	CC(=O)OCC[N+](C)(C)C		Commercial		60-31-1	0
GNPS00004_G3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G3	GLUTAMATE	C5H9NO4	N[C@@H](CCC(O)=O)C(O)=O		Commercial		56-86-0	2
GNPS00004_G4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G4	N-METHYLASPARTATE	C5H9NO4	CN[C@H](CC(O)=O)C(O)=O		Commercial		6384-92-5	2
GNPS00004_G5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G5	O-ACETYLSERINE	C5H9NO4	CC(=O)OC[C@H](N)C(O)=O		Commercial		66638-22-0	1
GNPS00004_G6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G6	N-ACETYLSERINE	C5H9NO4	CC(=O)N[C@@H](CO)C(O)=O		Commercial		97-14-3	2
GNPS00004_G7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G7	DIHYDROXYFUMARATE	C4H4O6	OC(O)=C(O)C(=O)C(O)=O		Commercial		199926-38-0	0
GNPS00004_G8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G8	CITRAMALATE	C5H8O5	CC(O)(CC(O)=O)C(O)=O		Commercial		1030365-02-6 (ANHYDROUS)	1
GNPS00004_G9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G9	METHIONINE	C5H11NO2S	CSCC[C@H](N)C(O)=O		Commercial		63-68-3	2
GNPS00004_G10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G10	TARTRATE	C4H6O6	O[C@H]([C@@H](O)C(O)=O)C(O)=O		Commercial		87-69-4	1
GNPS00004_G11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G11	TARTRATE	C4H6O6	O[C@@H]([C@H](O)C(O)=O)C(O)=O		Commercial		147-71-7	1
GNPS00004_G12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G12	MESO-TARTRATE	C4H606	C(C(C(=O)O)O)(C(=O)O)O.O		Commercial		5990-63-6	0
GNPS00004_H1_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H1	2-HYDROXY-4-(METHYLTHIO)BUTANOATE	C5H10O3S	CSCCC(O)C(O)=O		Commercial		4857-44-7	2
GNPS00004_H2_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H2	GUANINE	C5H5N5O	NC1=NC(=O)C2=C(N1)N=CN2		Commercial		73-40-5	3
GNPS00004_H3_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H3	XANTHINE	C5H4N4O2	O=C1NC2=C(NC=N2)C(=O)N1		Commercial		69-89-6	2
GNPS00004_H4_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H4	P-HYDROXYPHENYLACETATE	C8H8O3	NCCC(O)=O		Commercial		156-38-7	0
GNPS00004_H5_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H5	MANDELATE	C8H8O3	O[C@H](C(O)=O)C1=CC=CC=C1		Commercial		90-64-2	1
GNPS00004_H6_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H6	2-HYDROXYPHENYLACETATE	C8H8O3	OC(=O)CC1=CC=CC=C1O		Commercial		611-71-2	1
GNPS00004_H7_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H7	3-SULFINOALANINE	C3H7NO4S	N[C@@H](CS(=O)=O)C(O)=O		Commercial		207121-48-0	2
GNPS00004_H8_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H8	3-HYDROXYANTHRANILATE	C7H7NO3	NC1=C(O)C=CC=C1C(O)=O		Commercial		548-93-6	3
GNPS00004_H9_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H9	3-AMINO-5-HYDROXYBENZOATE	C7H7NO3	C1=C(C=C(C=C1N)O)C(=O)O		Commercial		76045-71-1	2
GNPS00004_H10_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H10	3-AMINO-4-HYDROXYBENZOATE	C7H7NO3	C1=CC(=C(C=C1C(=O)O)N)O		Commercial		1571-72-8	2
GNPS00004_H11_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H11	DOPAMINE	C8H11NO2	NCCC1=CC=C(O)C(O)=C1		Commercial		62-31-7	2
GNPS00004_H12_n.mzXML	GNPS00004	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H12	P-OCTOPAMINE	C8H11NO2	NC[C@H](O)C1=CC=C(O)C=C1		Commercial		0770-05-08	2
__n.mzXML																		0
GNPS00003_A2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A2	TRIMETHYLAMINE	C3H9N	CN(C)C		Commercial		593-81-7	0
GNPS00003_A3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A3	ETHANOLAMINE	C2H7NO	NCCO		Commercial		141-43-5	0
GNPS00003_A4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A4	PYRAZOLE	C3H4N2	C1=CNN=C1		Commercial		288-13-1	0
GNPS00003_A5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A5	2-PROPENOATE	C3H4O2	OC(=O)C=C		Commercial		79-10-7	0
GNPS00003_A6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A6	2-METHYLPROPANAL	C4H8O	CC(C)C=NO		Commercial		151-00-8	0
GNPS00003_A7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A7	METHYLGUANIDINE	C2H7N3	CNC(N)=N		Commercial		22661-87-6	0
GNPS00003_A8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A8	GLYOXYLATE	C2H2O3	OC(=O)C=O		Commercial		563-96-2	0
GNPS00003_A9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A9	PROPIONATE	C3H6O2	CCC(O)=O		Commercial		137-40-6	0
GNPS00003_A10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A10	PROPANOATE	C3H6O2	CCC(O)=O		Commercial		79-09-4	0
GNPS00003_A11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A11	1,3-DIAMINOPROPANE	C3H10N2	NCCCN		Commercial		109-76-2	0
GNPS00003_A12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A12	GLYCINE	C2H5NO2	NCC(O)=O		Commercial		56-40-6	0
GNPS00003_B1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B1	THIOUREA	CH4N2S	NC(N)=S		Commercial		62-56-6	0
GNPS00003_B2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B2	GLYCOLATE	C2H4O3	OCC(O)=O		Commercial		79-14-1	0
GNPS00003_B3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B3	2-METHOXYETHANOL	C3H8O2	COCCO		Commercial		109-86-4	0
GNPS00003_B4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B4	CYSTEAMINE	C2H7NS	NCCS		Commercial		60-23-1	0
GNPS00003_B5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B5	PYRIMIDINE	C4H4N2	C1=CN=CN=C1		Commercial		289-95-2	0
GNPS00003_B6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B6	CYCLOPENTANONE	C5H8O	O=C1CCCC1		Commercial		120-92-3	0
GNPS00003_B7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B7	PRENOL	C5H10O	CC(C)=CCO		Commercial		556-82-1	0
GNPS00003_B8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B8	ISOBUTYRATE	C4H8O2	CC(C)C(O)=O		Commercial		79-31-2	0
GNPS00003_B9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B9	BUTANOATE	C4H8O2	CCCC(O)=O		Commercial		107-92-6	0
GNPS00003_B10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B10	ACETOIN	C4H8O2	OC(=O)CC1=CC=C(O)C=C1		Commercial		513-86-0	0
GNPS00003_B11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B11	PUTRESCINE	C4H12N2	NCCCCN		Commercial		110-60-1	0
GNPS00003_B12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B12	PUTRESCINE	C4H12N2	NCCCCN		Commercial		333-93-7	0
GNPS00003_C1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C1	SARCOSINE	C3H7NO2	CNCC(O)=O		Commercial		107-97-1	0
GNPS00003_C2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C2	L-ALANINE	C3H7NO2	C[C@H](N)C(O)=O		Commercial		56-41-7	0
GNPS00003_C3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C3	D-ALANINE	C3H7NO2	C[C@@H](N)C(O)=O		Commercial		338-69-2	0
GNPS00003_C4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C4	BETA-ALANINE	C3H7NO2	C(CN)C(=O)O		Commercial		107-95-9	0
GNPS00003_C5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C5	OXALATE	C2H2O4	OC(=O)C(O)=O		Commercial		6153-56-6	0
GNPS00003_C6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C6	LACTATE	C3H6O3	C[C@H](O)C(O)=O		Commercial		79-33-4	0
GNPS00003_C7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C7	GLYCERALDEHYDE	C3H6O3	OCC(O)C=O		Commercial		367-47-5	0
GNPS00003_C8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C8	2,3-BUTANEDIOL	C4H10O2	C[C@@H](O)[C@@H](C)O		Commercial		24347-58-8	0
GNPS00003_C9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C9	GLYCEROL	C3H8O3	OCC(O)CO		Commercial		56-81-5	0
GNPS00003_C10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C10	ANILINE	C6H7N	NC1=CC=CC=C1		Commercial		62-53-3	0
GNPS00003_C11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C11	PHENOL	C6H6O	OC1=CC=CC=C1		Commercial		108-95-2	0
GNPS00003_C12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C12	2-HYDROXYPYRIDINE	C5H5NO	OC1=CC=CC=N1		Commercial		0142-08-05	0
GNPS00003_D1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D1	MALEIMIDE	C4H3NO2	C1=CC(=O)NC1=O		Commercial		541-59-3	0
GNPS00003_D2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D2	5-VALEROLACTONE	C5H8O2	C1CCOC(=O)C1		Commercial		542-28-9	1
GNPS00003_D3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D3	1-AMINOCYCLOPROPANECARBOXYLATE	C4H7NO2	NC1(CC1)C(O)=O		Commercial		22059-21-8	0
GNPS00003_D4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D4	SUCCINATE SEMIALDEHYDE	C4H6O3	OC(=O)CCC=O		Commercial		692-29-5	0
GNPS00003_D5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D5	2-OXOBUTANOATE	C4H6O3	CCC(=O)C(O)=O		Commercial		600-18-0	0
GNPS00003_D6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D6	PENTANOATE	C5H10O2	CCCCC(O)=O		Commercial		109-52-4	0
GNPS00003_D7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D7	CADAVERINE	C5H14N2	NCCCCCN		Commercial		1476-39-7	0
GNPS00003_D8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D8	N-FORMYLGLYCINE	C3H5NO3	C(C(=O)O)NC=O		Commercial		2491-15-8	1
GNPS00003_D9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D9	GAMMA-AMINOBUTYRATE	C4H9NO2	NCCCC(O)=O		Commercial		56-12-2	0
GNPS00003_D10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D10	AMINOISOBUTANOATE	C4H9NO2	CC(CN)C(O)=O		Commercial		144-90-1	0
GNPS00003_D11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D11	2-AMINOISOBUTYRATE	C4H9NO2	CC(C)(N)C(O)=O		Commercial		62-57-7	1
GNPS00003_D12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D12	MALONATE	C3H4O4	OC(=O)CC(O)=O		Commercial		141-82-2	0
GNPS00003_E1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E1	HYDROXYPYRUVATE	C3H4O4	OCC(=O)C(O)=O		Commercial		1113-60-6	0
GNPS00003_E2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E2	ALPHA-HYDROXYISOBUTYRATE	C4H8O3	CC(C)(O)C(O)=O		Commercial		594-61-6	0
GNPS00003_E3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E3	3-HYDROXYBUTANOATE	C4H8O3	C[C@@H](O)CC(O)=O		Commercial		300-85-6	0
GNPS00003_E4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E4	2-HYDROXYBUTYRATE	C4H8O3	CCC(O)C(O)=O		Commercial		5094-24-6	0
GNPS00003_E5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E5	2,3-DIAMINOPROPIONATE	C3H8N2O2	NC[C@H](N)C(O)=O		Commercial		54897-59-5	0
GNPS00003_E6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E6	CHOLINE	C5H14NO	C[N+](C)(C)CCO		Commercial		123-41-1	0
GNPS00003_E7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E7	SERINE	C3H7NO3	N[C@@H](CO)C(O)=O		Commercial		56-45-1	1
GNPS00003_E8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E8	DIETHANOLAMINE	C4H11NO2	OCCNCCO		Commercial		111-42-2	0
GNPS00003_E9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E9	GLYCERATE	C3H6O4	OC[C@@H](O)C(O)=O		Commercial		473-81-4	0
GNPS00003_E10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E10	GLYCERATE	C3H6O4	OC[C@@H](O)C(O)=O		Commercial		6000-41-5	0
GNPS00003_E11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E11	BENZALDEHYDE	C7H6O	O=CC1=CC=CC=C1		Commercial		100-52-7	0
GNPS00003_E12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E12	BENZYLAMINE	C7H9N	NCC1=CC=CC=C1		Commercial		100-46-9	0
GNPS00003_F1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F1	2,5-DIMETHYLPYRAZINE	C6H8N2	CC1=CN=C(C)C=N1		Commercial		123-32-0	0
GNPS00003_F2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F2	HYPOTAURINE	C2H7NO2S	NCCS(O)=O		Commercial		300-84-5	1
GNPS00003_F3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F3	2-AMINOPHENOL	C6H7NO	C1=CC=C(C(=C1)N)O		Commercial		95-55-6	1
GNPS00003_F4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F4	PYROCATECHOL	C6H6O2	OC1=CC=CC=C1O		Commercial		120-80-9	0
GNPS00003_F5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F5	CYTOSINE	C4H5N3O	NC1=CC=NC(=O)N1		Commercial		71-30-7	4
GNPS00003_F6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F6	HISTAMINE	C5H9N3	NCCC1=CNC=N1		Commercial		56-92-8	1
GNPS00003_F7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F7	URACIL	C4H4N2O2	O=C1NC=CC(=O)N1		Commercial		66-22-8	1
GNPS00003_F8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F8	SORBATE	C6H8O2	CC=CC=CC(=O)O		Commercial		24634-61-5	1
GNPS00003_F9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F9	CREATININE	C4H7N3O	CN1CC(=O)NC1=N		Commercial		60-27-5	3
GNPS00003_F10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F10	DIHYDROURACIL	C4H6N2O2	O=C1CCNC(=O)N1		Commercial		0504-07-04	0
GNPS00003_F11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F11	MALEAMATE	C4H5NO3	C(=CC(=O)O)C(=O)N		Commercial		557-24-4	0
GNPS00003_F12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F12	PROLINE	C5H9NO2	OC(=O)[C@@H]1CCCN1		Commercial		147-85-3	1
GNPS00003_G1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G1	MALEATE	C4H4O4	OC(=O)\C=C/C(O)=O		Commercial		110-16-7	0
GNPS00003_G2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G2	FUMARATE	C4H4O4	OC(=O)\C=C\C(O)=O		Commercial		110-17-8	0
GNPS00003_G3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G3	HEXANOATE	C6H12O2	CCCCCC(O)=O		Commercial		142-62-1	0
GNPS00003_G4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G4	TRANS-CYCLOHEXANEDIOL	C6H12O2	C1CCC(C(C1)O)O		Commercial		1460-57-7	0
GNPS00003_G5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G5	HOMOCYSTEINE THIOLACTONE	C4H7NOS	NC1CCSC1=O		Commercial		31828-68-9	0
GNPS00003_G6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G6	N-ACETYLGLYCINE	C4H7NO3	CC(=O)NCC(O)=O		Commercial		543-24-8	0
GNPS00003_G7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G7	GUANIDINOACETATE	C3H7N3O2	NC(=N)NCC(O)=O		Commercial		352-97-6	0
GNPS00003_G8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G8	VALINE	C5H11NO2	CC(C)[C@H](N)C(O)=O		Commercial		72-18-4	3
GNPS00003_G9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G9	BETAINE	C5H11NO2	C[N+](C)(C)CC([O-])=O		Commercial		107-43-7	4
GNPS00003_G10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G10	NORVALINE	C5H11NO2	CCC[C@@H](N)C(O)=O		Commercial		6600-40-4	3
GNPS00003_G11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G11	5-AMINOPENTANOATE	C5H11NO2	NCCCCC(O)=O		Commercial		660-88-8	3
GNPS00003_G12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G12	METHYL 4-AMINOBUTYRATE	C5H11NO2	COC(CCCN)=O		Commercial		13031-60-2	3
GNPS00003_H1_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H1	MESOXALATE	C3H2O5	OC(=O)C(=O)C(O)=O		Commercial		31635-99-1	0
GNPS00003_H2_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H2	SUCCINATE	C4H6O4	OC(=O)CCC(O)=O		Commercial		110-15-6	0
GNPS00003_H3_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H3	METHYLMALONATE	C4H6O4	CC(C(O)=O)C(O)=O		Commercial		0516-05-02	0
GNPS00003_H4_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H4	THREONINE	C4H9NO3	C[C@@H](O)[C@H](N)C(O)=O		Commercial		72-19-5	1
GNPS00003_H5_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H5	HOMOSERINE	C4H9NO3	N[C@@H](CCO)C(O)=O		Commercial		672-15-1	1
GNPS00003_H6_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H6	ALLOTHREONINE	C4H9NO3	C[C@H](O)[C@H](N)C(O)=O		Commercial		28954-12-3	1
GNPS00003_H7_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H7	GLYCOLALDEHYDE	C2H4O2	C(C=O)O		Commercial		23147-58-2	0
GNPS00003_H8_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H8	PURINE	C5H4N4	N1C=NC2=C1C=NC=N2		Commercial		120-73-0	1
GNPS00003_H9_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H9	CYSTEINE	C3H7NO2S	N[C@@H](CS)C(O)=O		Commercial		52-90-4	0
GNPS00003_H10_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H10	BENZOATE	C7H6O2	OC(=O)C1=CC=CC=C1		Commercial		65-85-0	0
GNPS00003_H11_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H11	BENZOATE	C7H6O2	OC(=O)C1=CC=CC=C1		Commercial		532-32-1	0
GNPS00003_H12_p.mzXML	GNPS00003	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H12	4-HYDROXYBENZALDEHYDE	C7H6O2	OC1=CC=C(C=O)C=C1		Commercial		123-08-0	0
GNPS00003_A1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A1	FORMAMIDE	CH3NO	NC=O		Commercial		75-12-7	0
GNPS00003_A2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A2	TRIMETHYLAMINE	C3H9N	CN(C)C		Commercial		593-81-7	0
GNPS00003_A3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A3	ETHANOLAMINE	C2H7NO	NCCO		Commercial		141-43-5	0
GNPS00003_A4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A4	PYRAZOLE	C3H4N2	C1=CNN=C1		Commercial		288-13-1	0
GNPS00003_A5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A5	2-PROPENOATE	C3H4O2	OC(=O)C=C		Commercial		79-10-7	0
GNPS00003_A6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A6	2-METHYLPROPANAL	C4H8O	CC(C)C=NO		Commercial		151-00-8	0
GNPS00003_A7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A7	METHYLGUANIDINE	C2H7N3	CNC(N)=N		Commercial		22661-87-6	0
GNPS00003_A8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A8	GLYOXYLATE	C2H2O3	OC(=O)C=O		Commercial		563-96-2	0
GNPS00003_A9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A9	PROPIONATE	C3H6O2	CCC(O)=O		Commercial		137-40-6	0
GNPS00003_A10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A10	PROPANOATE	C3H6O2	CCC(O)=O		Commercial		79-09-4	0
GNPS00003_A11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A11	1,3-DIAMINOPROPANE	C3H10N2	NCCCN		Commercial		109-76-2	0
GNPS00003_A12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	A12	GLYCINE	C2H5NO2	NCC(O)=O		Commercial		56-40-6	0
GNPS00003_B1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B1	THIOUREA	CH4N2S	NC(N)=S		Commercial		62-56-6	0
GNPS00003_B2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B2	GLYCOLATE	C2H4O3	OCC(O)=O		Commercial		79-14-1	0
GNPS00003_B3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B3	2-METHOXYETHANOL	C3H8O2	COCCO		Commercial		109-86-4	0
GNPS00003_B4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B4	CYSTEAMINE	C2H7NS	NCCS		Commercial		60-23-1	0
GNPS00003_B5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B5	PYRIMIDINE	C4H4N2	C1=CN=CN=C1		Commercial		289-95-2	0
GNPS00003_B6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B6	CYCLOPENTANONE	C5H8O	O=C1CCCC1		Commercial		120-92-3	0
GNPS00003_B7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B7	PRENOL	C5H10O	CC(C)=CCO		Commercial		556-82-1	0
GNPS00003_B8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B8	ISOBUTYRATE	C4H8O2	CC(C)C(O)=O		Commercial		79-31-2	0
GNPS00003_B9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B9	BUTANOATE	C4H8O2	CCCC(O)=O		Commercial		107-92-6	0
GNPS00003_B10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B10	ACETOIN	C4H8O2	OC(=O)CC1=CC=C(O)C=C1		Commercial		513-86-0	0
GNPS00003_B11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B11	PUTRESCINE	C4H12N2	NCCCCN		Commercial		110-60-1	0
GNPS00003_B12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	B12	PUTRESCINE	C4H12N2	NCCCCN		Commercial		333-93-7	0
GNPS00003_C1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C1	SARCOSINE	C3H7NO2	CNCC(O)=O		Commercial		107-97-1	0
GNPS00003_C2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C2	L-ALANINE	C3H7NO2	C[C@H](N)C(O)=O		Commercial		56-41-7	0
GNPS00003_C3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C3	D-ALANINE	C3H7NO2	C[C@@H](N)C(O)=O		Commercial		338-69-2	0
GNPS00003_C4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C4	BETA-ALANINE	C3H7NO2	C(CN)C(=O)O		Commercial		107-95-9	0
GNPS00003_C5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C5	OXALATE	C2H2O4	OC(=O)C(O)=O		Commercial		6153-56-6	0
GNPS00003_C6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C6	LACTATE	C3H6O3	C[C@H](O)C(O)=O		Commercial		79-33-4	0
GNPS00003_C7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C7	GLYCERALDEHYDE	C3H6O3	OCC(O)C=O		Commercial		367-47-5	0
GNPS00003_C8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C8	2,3-BUTANEDIOL	C4H10O2	C[C@@H](O)[C@@H](C)O		Commercial		24347-58-8	0
GNPS00003_C9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C9	GLYCEROL	C3H8O3	OCC(O)CO		Commercial		56-81-5	0
GNPS00003_C10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C10	ANILINE	C6H7N	NC1=CC=CC=C1		Commercial		62-53-3	0
GNPS00003_C11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C11	PHENOL	C6H6O	OC1=CC=CC=C1		Commercial		108-95-2	0
GNPS00003_C12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	C12	2-HYDROXYPYRIDINE	C5H5NO	OC1=CC=CC=N1		Commercial		0142-08-05	0
GNPS00003_D1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D1	MALEIMIDE	C4H3NO2	C1=CC(=O)NC1=O		Commercial		541-59-3	0
GNPS00003_D2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D2	5-VALEROLACTONE	C5H8O2	C1CCOC(=O)C1		Commercial		542-28-9	1
GNPS00003_D3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D3	1-AMINOCYCLOPROPANECARBOXYLATE	C4H7NO2	NC1(CC1)C(O)=O		Commercial		22059-21-8	0
GNPS00003_D4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D4	SUCCINATE SEMIALDEHYDE	C4H6O3	OC(=O)CCC=O		Commercial		692-29-5	0
GNPS00003_D5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D5	2-OXOBUTANOATE	C4H6O3	CCC(=O)C(O)=O		Commercial		600-18-0	0
GNPS00003_D6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D6	PENTANOATE	C5H10O2	CCCCC(O)=O		Commercial		109-52-4	0
GNPS00003_D7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D7	CADAVERINE	C5H14N2	NCCCCCN		Commercial		1476-39-7	0
GNPS00003_D8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D8	N-FORMYLGLYCINE	C3H5NO3	C(C(=O)O)NC=O		Commercial		2491-15-8	1
GNPS00003_D9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D9	GAMMA-AMINOBUTYRATE	C4H9NO2	NCCCC(O)=O		Commercial		56-12-2	0
GNPS00003_D10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D10	AMINOISOBUTANOATE	C4H9NO2	CC(CN)C(O)=O		Commercial		144-90-1	0
GNPS00003_D11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D11	2-AMINOISOBUTYRATE	C4H9NO2	CC(C)(N)C(O)=O		Commercial		62-57-7	1
GNPS00003_D12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	D12	MALONATE	C3H4O4	OC(=O)CC(O)=O		Commercial		141-82-2	0
GNPS00003_E1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E1	HYDROXYPYRUVATE	C3H4O4	OCC(=O)C(O)=O		Commercial		1113-60-6	0
GNPS00003_E2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E2	ALPHA-HYDROXYISOBUTYRATE	C4H8O3	CC(C)(O)C(O)=O		Commercial		594-61-6	0
GNPS00003_E3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E3	3-HYDROXYBUTANOATE	C4H8O3	C[C@@H](O)CC(O)=O		Commercial		300-85-6	0
GNPS00003_E4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E4	2-HYDROXYBUTYRATE	C4H8O3	CCC(O)C(O)=O		Commercial		5094-24-6	0
GNPS00003_E5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E5	2,3-DIAMINOPROPIONATE	C3H8N2O2	NC[C@H](N)C(O)=O		Commercial		54897-59-5	0
GNPS00003_E6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E6	CHOLINE	C5H14NO	C[N+](C)(C)CCO		Commercial		123-41-1	0
GNPS00003_E7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E7	SERINE	C3H7NO3	N[C@@H](CO)C(O)=O		Commercial		56-45-1	1
GNPS00003_E8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E8	DIETHANOLAMINE	C4H11NO2	OCCNCCO		Commercial		111-42-2	0
GNPS00003_E9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E9	GLYCERATE	C3H6O4	OC[C@@H](O)C(O)=O		Commercial		473-81-4	0
GNPS00003_E10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E10	GLYCERATE	C3H6O4	OC[C@@H](O)C(O)=O		Commercial		6000-41-5	0
GNPS00003_E11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E11	BENZALDEHYDE	C7H6O	O=CC1=CC=CC=C1		Commercial		100-52-7	0
GNPS00003_E12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	E12	BENZYLAMINE	C7H9N	NCC1=CC=CC=C1		Commercial		100-46-9	0
GNPS00003_F1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F1	2,5-DIMETHYLPYRAZINE	C6H8N2	CC1=CN=C(C)C=N1		Commercial		123-32-0	0
GNPS00003_F2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F2	HYPOTAURINE	C2H7NO2S	NCCS(O)=O		Commercial		300-84-5	1
GNPS00003_F3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F3	2-AMINOPHENOL	C6H7NO	C1=CC=C(C(=C1)N)O		Commercial		95-55-6	1
GNPS00003_F4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F4	PYROCATECHOL	C6H6O2	OC1=CC=CC=C1O		Commercial		120-80-9	0
GNPS00003_F5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F5	CYTOSINE	C4H5N3O	NC1=CC=NC(=O)N1		Commercial		71-30-7	4
GNPS00003_F6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F6	HISTAMINE	C5H9N3	NCCC1=CNC=N1		Commercial		56-92-8	1
GNPS00003_F7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F7	URACIL	C4H4N2O2	O=C1NC=CC(=O)N1		Commercial		66-22-8	1
GNPS00003_F8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F8	SORBATE	C6H8O2	CC=CC=CC(=O)O		Commercial		24634-61-5	1
GNPS00003_F9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F9	CREATININE	C4H7N3O	CN1CC(=O)NC1=N		Commercial		60-27-5	3
GNPS00003_F10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F10	DIHYDROURACIL	C4H6N2O2	O=C1CCNC(=O)N1		Commercial		0504-07-04	0
GNPS00003_F11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F11	MALEAMATE	C4H5NO3	C(=CC(=O)O)C(=O)N		Commercial		557-24-4	0
GNPS00003_F12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	F12	PROLINE	C5H9NO2	OC(=O)[C@@H]1CCCN1		Commercial		147-85-3	1
GNPS00003_G1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G1	MALEATE	C4H4O4	OC(=O)\C=C/C(O)=O		Commercial		110-16-7	0
GNPS00003_G2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G2	FUMARATE	C4H4O4	OC(=O)\C=C\C(O)=O		Commercial		110-17-8	0
GNPS00003_G3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G3	HEXANOATE	C6H12O2	CCCCCC(O)=O		Commercial		142-62-1	0
GNPS00003_G4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G4	TRANS-CYCLOHEXANEDIOL	C6H12O2	C1CCC(C(C1)O)O		Commercial		1460-57-7	0
GNPS00003_G5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G5	HOMOCYSTEINE THIOLACTONE	C4H7NOS	NC1CCSC1=O		Commercial		31828-68-9	0
GNPS00003_G6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G6	N-ACETYLGLYCINE	C4H7NO3	CC(=O)NCC(O)=O		Commercial		543-24-8	0
GNPS00003_G7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G7	GUANIDINOACETATE	C3H7N3O2	NC(=N)NCC(O)=O		Commercial		352-97-6	0
GNPS00003_G8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G8	VALINE	C5H11NO2	CC(C)[C@H](N)C(O)=O		Commercial		72-18-4	3
GNPS00003_G9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G9	BETAINE	C5H11NO2	C[N+](C)(C)CC([O-])=O		Commercial		107-43-7	4
GNPS00003_G10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G10	NORVALINE	C5H11NO2	CCC[C@@H](N)C(O)=O		Commercial		6600-40-4	3
GNPS00003_G11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G11	5-AMINOPENTANOATE	C5H11NO2	NCCCCC(O)=O		Commercial		660-88-8	3
GNPS00003_G12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	G12	METHYL 4-AMINOBUTYRATE	C5H11NO2	COC(CCCN)=O		Commercial		13031-60-2	3
GNPS00003_H1_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H1	MESOXALATE	C3H2O5	OC(=O)C(=O)C(O)=O		Commercial		31635-99-1	0
GNPS00003_H2_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H2	SUCCINATE	C4H6O4	OC(=O)CCC(O)=O		Commercial		110-15-6	0
GNPS00003_H3_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H3	METHYLMALONATE	C4H6O4	CC(C(O)=O)C(O)=O		Commercial		0516-05-02	0
GNPS00003_H4_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H4	THREONINE	C4H9NO3	C[C@@H](O)[C@H](N)C(O)=O		Commercial		72-19-5	1
GNPS00003_H5_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H5	HOMOSERINE	C4H9NO3	N[C@@H](CCO)C(O)=O		Commercial		672-15-1	1
GNPS00003_H6_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H6	ALLOTHREONINE	C4H9NO3	C[C@H](O)[C@H](N)C(O)=O		Commercial		28954-12-3	1
GNPS00003_H7_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H7	GLYCOLALDEHYDE	C2H4O2	C(C=O)O		Commercial		23147-58-2	0
GNPS00003_H8_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H8	PURINE	C5H4N4	N1C=NC2=C1C=NC=N2		Commercial		120-73-0	1
GNPS00003_H9_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H9	CYSTEINE	C3H7NO2S	N[C@@H](CS)C(O)=O		Commercial		52-90-4	0
GNPS00003_H10_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H10	BENZOATE	C7H6O2	OC(=O)C1=CC=CC=C1		Commercial		65-85-0	0
GNPS00003_H11_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H11	BENZOATE	C7H6O2	OC(=O)C1=CC=CC=C1		Commercial		532-32-1	0
GNPS00003_H12_n.mzXML	GNPS00003	Kelly Weldon	ESI	Negative	Orbitrap	1.0	Dorrestein	2019_dorrestein	20191008.0	H12	4-HYDROXYBENZALDEHYDE	C7H6O2	OC1=CC=C(C=O)C=C1		Commercial		123-08-0	0
__n.mzXML																		0
GNPS00002_A2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A2	SQUALENE	C30H50	CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C		Commercial	11975273.0	0111-02-04	0
GNPS00002_A3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A3	4-COUMARATE	C9H8O3	OC(=O)\C=C\C1=CC=C(O)C=C1		Commercial	637542.0	501-98-4	2
GNPS00002_A4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A4	NONANOATE	C9H18O2	CCCCCCCCC(O)=O		Commercial	8158.0	112-05-0	0
GNPS00002_A5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A5	ESTRADIOL-17ALPHA	C18H24O2	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O		Commercial	68570.0	57-91-0	1
GNPS00002_A6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A6	CAPRYLATE	C8H16O2	CCCCCCCC(O)=O		Commercial	379.0	0124-07-02	0
GNPS00002_A7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A7	URSODEOXYCHOLATE	C24H40O4	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C		Commercial	31401.0	128-13-2	2
GNPS00002_A8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A8	PETROSELINATE	C18H34O2	CCCCCCCCCCC/C=C\CCCCC(O)=O		Commercial	5281125.0	593-39-5	0
GNPS00002_A9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A9	DIPALMITOYLGLYCEROL	C35H68O5	CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC		Commercial	644078.0	30334-71-5	0
GNPS00002_A10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A10	DEOXYCHOLATE	C24H40O4	[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C		Commercial	222528.0	83-44-3	3
GNPS00002_A11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A11	LITHOCHOLATE	C24H40O3	[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2C[C@H](O)CC[C@]12C		Commercial	11740284.0	434-13-9	0
GNPS00002_A12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	A12	PROTOPORPHYRIN	C34H34N4O4	CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O		Commercial	4971.0	0553-12-8	0
GNPS00002_B1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B1	HEPTANOATE	C7H14O2	CCCCCCC(O)=O		Commercial	8094.0	111-14-8	0
GNPS00002_B2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B2	RETINOL	C20H30O	C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C		Commercial	445354.0	68-26-8	0
GNPS00002_B3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B3	MENAQUINONE	C41H56O2	CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)C2=CC=CC=C2C1=O		Commercial	5280374.0	11032-49-8	0
GNPS00002_B4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B4	ELAIDATE	C18H34O2	CCCCCCCC\C=C\CCCCCCCC(O)=O		Commercial	445639.0	112-79-8	0
GNPS00002_B5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B5	CHENODEOXYCHOLATE	C24H40O4	CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C		Commercial	10133.0	474-25-9	2
GNPS00002_B6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B6	MYRISTATE	C14H28O2	CCCCCCCCCCCCCC(O)=O		Commercial	11005.0	544-63-8	0
GNPS00002_B7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B7	CHOLESTERYL OLEATE	C45H78O2	CCCCCCCC\C=C/CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@]3([H])[C@]4([H])CC[C@]([H])([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@]23[H])C1		Commercial	5283632.0	303-43-5	0
GNPS00002_B8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B8	ROSMARINATE	C18H16O8	OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C1=CC(O)=C(O)C=C1		Commercial	5281792.0	20283-92-5	1
GNPS00002_B9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B9	GLYCERYL TRIPALMITATE	C51H98O6	CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC		Commercial	11147.0	555-44-2	0
GNPS00002_B10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B10	CORTEXOLONE	C21H30O4	[H]C12CC[C@](O)(C(=O)CO)[C@@]1(C)CCC1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C		Commercial	53477676.0	152-58-9	2
GNPS00002_B11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B11	LITHOCHOLYLTAURINE	C26H45NO5S	C[C@H](CCC(=O)NCCS(O)(=O)=O)C1CCC2C3CCC4C[C@H](O)CC[C@]4(C)C3CC[C@]12C		Commercial	439763.0	6042-32-6	1
GNPS00002_B12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	B12	PALMITOLEATE	C16H30O2	CCCCCC\C=C/CCCCCCCC(O)=O		Commercial	445638.0	373-49-9	0
GNPS00002_C1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C1	PALMITATE	C16H32O2	CCCCCCCCCCCCCCCC(O)=O		Commercial	985.0	57-10-3	0
GNPS00002_C2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C2	LIOTHYRONINE	C15H12I3NO4	N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O		Commercial	5920.0	345957-19-9	1
GNPS00002_C3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C3	SPHINGANINE	C18H39NO2	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO		Commercial	91486.0	764-22-7	0
GNPS00002_C4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C4	LANOSTEROL	C30H50O	[H][C@@]1(CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3)[C@H](C)CCC=C(C)C		Commercial	246983.0	79-63-0	0
GNPS00002_C5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C5	LAURATE	C12H24O2	CCCCCCCCCCCC(O)=O		Commercial	3893.0	0143-07-07	0
GNPS00002_C6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C6	ARACHIDATE	C20H40O2	CCCCCCCCCCCCCCCCCCCC(O)=O		Commercial	10467.0	506-30-9	0
GNPS00002_C7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C7	ERUCATE	C22H42O2	CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O		Commercial	5281116.0	112-86-7	0
GNPS00002_C8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C8	DEOXYCHOLATE	C24H40O4	[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C		Commercial	222528.0	302-95-4	3
GNPS00002_C9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C9	KETOLEUCINE	C6H10O3	CC(C)CC(=O)C(=O)O		Commercial	70.0	NONE	0
GNPS00002_C10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C10	EICOSAPENTAENOATE	C20H30O2	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O		Commercial	446284.0	10417-94-4	0
GNPS00002_C11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C11	HEPTADECANOATE	C17H34O2	CCCCCCCCCCCCCCCCC(O)=O		Commercial	10465.0	0506-12-7	0
GNPS00002_C12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	C12	GLYCERYL TRIMYRISTATE	C45H86O6	CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC		Commercial	11148.0	555-45-3	0
GNPS00002_D1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D1	LINOLEATE	C18H32O2	CCCCC\C=C/C\C=C/CCCCCCCC(O)=O		Commercial	5280450.0	60-33-3	0
GNPS00002_D2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D2	SPHINGOMYELIN	C41H83N2O6P	CCCCCCCCCCCCCCCCCC(N[C@@](COP([O-])(OCC[N+](C)(C)C)=O)([C@](O)(/C=C/CCCCCCCCCCCCC)[H])[H])=O		Commercial	5283588.0	85187-10-6	0
GNPS00002_D3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D3	7-DEHYDROCHOLESTEROL	C27H44O	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC[C@@]1([H])C2=CC=C2C[C@@H](O)CC[C@]12C		Commercial	439423.0	434-16-2	0
GNPS00002_D4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D4	THYROXINE	C15H11I4NO4	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O		Commercial	5819.0	51-48-9	1
GNPS00002_D5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D5	BIS(2-ETHYLHEXYL)PHTHALATE	C24H38O4	CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC		Commercial	8343.0	117-81-7	0
GNPS00002_D6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D6	GAMMA-LINOLENATE	C18H30O2	CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O		Commercial	5280933.0	506-26-3	0
GNPS00002_D7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D7	OMEGA-HYDROXYDODECANOATE	C12H24O3	OCCCCCCCCCCCC(O)=O		Commercial	79034.0	505-95-3	4
GNPS00002_D8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D8	METHYL JASMONATE	C13H20O3	CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O		Commercial	5281929.0	39924-52-2	0
GNPS00002_D9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D9	DIPALMITOYL-PHOSPHATIDYLCHOLINE	C40H80NO8P	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC		Commercial	452110.0	8002-43-5	0
GNPS00002_D10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D10	HEXADECANOL	C16H34O	CCCCCCCCCCCCCCCCO		Commercial	2682.0	36653-82-4	0
GNPS00002_D11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D11	5,6 DIMETHYLBENZIMIDAZOLE	C9H10N2	CC1=CC2=C(C=C1C)N=CN2		Commercial	675.0	582-60-5	1
GNPS00002_D12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	D12	RETINOATE	C20H28O2	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O		Commercial	444795.0	302-79-4	0
GNPS00002_E1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E1	INDOLE	C8H7N	N1C=CC2=C1C=CC=C2		Commercial	798.0	120-72-9	0
GNPS00002_E2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E2	CHOLATE	C24H40O5	[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(O)=O		Commercial	221493.0	81-25-4	3
GNPS00002_E3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E3	PHYLLOQUINONE	C31H46O2	CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C		Commercial	5280483.0	84-80-0	0
GNPS00002_E4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E4	CHOLESTERYL PALMITATE	C43H76O2	[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCCCCCC)[C@H](C)CCCC(C)C		Commercial	246520.0	601-34-3	0
GNPS00002_E5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E5	QUINOLINE	C9H7N	C1=CC=C2N=CC=CC2=C1		Commercial	7047.0	91-22-5	0
GNPS00002_E6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E6	DOCOSAHEXAENOATE	C22H32O2	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O		Commercial	445580.0	6217-54-5	0
GNPS00002_E7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E7	DIETHYL 2-METHYL-3-OXOSUCCINATE	C9H14O5	CCOC(=O)C(C)C(=O)C(=O)OCC		Commercial	97750.0	759-65-9	0
GNPS00002_E8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E8	RETINYL PALMITATE	C36H60O2	CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C		Commercial	5280531.0	79-81-2	0
GNPS00002_E9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E9	2-UNDECANONE	C11H22O	CCCCCCCCCC(=O)C		Commercial	8163.0	0121-12-9	0
GNPS00002_E10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E10	1-HYDROXY-2-NAPHTHOATE	C11H8O3	C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O		Commercial	6844.0	86-48-6	0
GNPS00002_E11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E11	DIPALMITOYL-PHOSPHOETHANOLAMINE	C37H74NO8P	[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC		Commercial	445468.0	5681-36-7	0
GNPS00002_E12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	E12	PHENYLPYRUVATE	C9H8O3	OC(=O)C(=O)CC1=CC=CC=C1		Commercial	997.0	114-76-1	1
GNPS00002_F1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F1	TRANS-CINNAMATE	C9H8O2	OC(=O)\C=C\C1=CC=CC=C1		Commercial	444539.0	0140-10-3	2
GNPS00002_F2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F2	OLEATE	C18H34O2	CCCCCCCC\C=C/CCCCCCCC(O)=O		Commercial	445639.0	112-80-1	0
GNPS00002_F3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F3	STEARATE	C18H36O2	CCCCCCCCCCCCCCCCCC(O)=O		Commercial	5281.0	57-11-4	0
GNPS00002_F4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F4	BETA-CAROTENE	C40H56	C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C		Commercial	5280489.0	7235-40-7	0
GNPS00002_F5_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F5	25-HYDROXYCHOLESTEROL	C27H46O2	[H]C12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C		Commercial	65094.0	2140-46-7	0
GNPS00002_F6_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F6	NERVONATE	C24H46O2	CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O		Commercial	5281120.0	506-37-6	0
GNPS00002_F7_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F7	DESMOSTEROL	C27H44O	[H][C@@]12CC[C@H]([C@H](C)CCC=C(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C		Commercial	439577.0	0313-04-02	0
GNPS00002_F8_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F8	DEOXYCORTICOSTERONE ACETATE	C23H32O4	CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C		Commercial	5952.0	56-47-3	4
GNPS00002_F9_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F9	OLEOYL-GLYCEROL	C21H40O4	CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)O		Commercial	5283468.0	0111-03-05	1
GNPS00002_F10_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F10	ALPHA-TOCOPHEROL	C29H50O2	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C		Commercial	14985.0	59-02-9	0
GNPS00002_F11_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F11	GLYCEROL-MYRISTATE	C17H34O4	CCCCCCCCCCCCCC(=O)OCC(CO)O		Commercial	79050.0	589-68-4	3
GNPS00002_F12_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	F12	TRICOSANOATE	C23H46O2	CCCCCCCCCCCCCCCCCCCCCCC(O)=O		Commercial	17085.0	2433-96-7	0
GNPS00002_G1_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	G1	COENZYME Q10	C59H90O4	CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C		Commercial	5281915.0	303-98-0	0
GNPS00002_G2_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	G2	CORTISONE	C21H28O5	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C		Commercial	222786.0	53-06-5	3
GNPS00002_G3_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	G3	DECANOATE	C10H20O2	CCCCCCCCCC(O)=O		Commercial	2969.0	334-48-5	0
GNPS00002_G4_p.mzXML	GNPS00002	Kelly Weldon	ESI	Positive	Orbitrap	1.0	Dorrestein	2019_dorrestein	7/18/2019	G4	CORTICOSTERONE	C21H30O4	CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O		Commercial	5753.0	50-22-6	6
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
__n.mzXML																		0
